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Chapter 1 
General introduction and scope of thesis 
 
Cancer is one of the most dangerous diseases that can cause death of the sufferer. It is a 
generic term that encompasses a group of diseases characterized by an uncontrolled 
proliferation of cells. Many patients who succumb to cancer do not die as a result of the 
primary tumor, but because of the systemic effects of metastases on other regions away from 
the original site [1–3]. The cancer may spread to more distant parts of the body through the 
lymphatic system or bloodstream. Cancer can be detected in a number of ways, including the 
presence of certain signs and symptoms, screening tests, or medical imaging. Cancer is 
usually treated with chemotherapy, radiation therapy and surgery, but most often, the main 
cancer treatment is chemotherapy utilizing highly potent drugs. Treating cancer is a challenge 
because cancer chemotherapeutic agents are cytotoxic and could rarely differentiate cancer 
cells from normal cells. This leads to the destruction or impairment of vital organs in addition 
to killing cancer cells even at therapeutic dose levels, if their bio-distribution is not properly 
controlled and the therapeutic agents not targeted towards the cancer cells or tissues [1,2]. 
Clearly, this lack of tumor-specific treatment is one of the many hurdles that need to be 
overcome by current chemotherapy. However, in chemotherapy, patients also have to be 
administered a combination of drugs that increase in dose over time, which results in severe 
side effects, including toxicity and multidrug resistance (MDR). Hence, development of new 
delivery vehicles to transport chemotherapeutic reagents into tumor cells with high efficiency 
and specificity is necessary to overcome drug resistance as well as to reduce side effects [4,5]. 
An ideal solution to current chemotherapy limitations would be to deliver a biologically 
effective concentration of anti-cancer agents to the tumor tissues with very high specificity.  
Carbon nanotubes have a unique structure on the nanoscale that allows them to enter 
cells easily and to conjugate various therapeutic molecules. Their small size, high surface area, 
inert chemical composition, and unique physical properties have made them extensively 
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investigated for transport of DNA, nucleic acids, drugs, and a variety of other potential 
therapeutics [6–8]. Additionally, their pure carbon composition makes them possess good 
biocompatibility. In light of these factors, carbon nanotubes have become a new class of 
promising candidates for a delivery system. Carbon nanotubes that possess unique chemical 
and physical properties have received a great attention for drug delivery applications. Carbon 
nanotubes with proper modifications can be used as a drug-delivery vehicles or ‘nanocarriers’ 
in cancer therapy and other areas of medicine without causing toxicity to healthy tissue and 
permit for a prolonged release period of the drug [9]. In this research, SWCNTs were used for 
the developing of carbon nanotubes as a drug container because in drug delivery SWCNTs are 
known to be more efficient than MWCNTs. It has been shown that a SWCNTs-anticancer 
drug complex has a much longer blood circulation time than the anticancer drug on its own, 
which can lead to more prolonged and sustained uptake of the drug by tumor cells via the 
enhanced permeability and retention effect. Various reports have suggested that once the 
functionalized SWCNTs release the drug into a specific area, it is gradually excreted from the 
body via the biliary pathway and finally in the feces. This suggests that SWCNTs are suitable 
candidates for drug delivery and a promising nano platform for future cancer therapeutics 
[10,11]. 
Based on mentioned facts above, the aim of this study is to explore the potentialities of 
single-walled carbon nanotubes (SWCNTs) to be developed as a suitable nanocarrier for 
delivering anticancer drugs in the cancer therapy. In Chapter 2, the brief overview relating to 
carbon nanotubes particularly SWCNTs, cancer, and carbon nanostructures as multi-
functional drug delivery platforms including carbon nanotubes as drug delivery tools are 
described respectively. Chapter 3 presents the developed method of purification and 
oxidation of SWCNTs in order to produce feasible oxidized SWCNTs (Ox-SWCNTs) that 
essentially free of metals, well dispersed in aqueous solutions, and contain abundant 
carboxylic acid groups functional groups which suitable for use as a starting material in 
biomedicine research involving SWCNTs. Evaluation of the purity, structure and surface 
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modification on SWCNTs materials from this process using a number of different analytical 
techniques, including Raman spectroscopy, infrared spectroscopy, thermogravimetry analysis 
(TGA), field-emission scanning electron microscopy (FE–SEM), transmission electron 
microscopy (TEM), Boehm’s neutralizing titration and determination of pore structures by 
adsorption of nitrogen at 77 K, is also presented in this chapter. Chapter 4 reviews the 
interaction of Ox-SWCNTs with camptothecin (CPT) based on adsorption process in order to 
develop a potential drug carrier for this water-insoluble anticancer agent. Systematic 
evaluation of this interaction is presented in this chapter. Chapter 5 describes the 
comprehensive study for the functionalization of Ox-SWCNTs with another water-insoluble 
anticancer drug methotrexate (MTX). Conjugation of MTX on Ox-SWCNTs as a platform of 
drug attachment was done via non-covalent conjugation.  
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Chapter 2 
Carbon nanotubes as multi-functional drug delivery platforms for 
anticancer drugs  
 
Nanotechnology is a rapidly expanding field, encompassing the development of man-
made materials in the 5-200 nanometer size range. These materials are very diverse and hold 
much promise in many fields such as communications, engineering, robotics, physics, 
chemistry, and biomedicine. In biomedicine, nanotechnology has been utilized for 
therapeutic, diagnostic, drug delivery, and the development of treatments for a variety of 
diseases and disorders [1]. The use of nanoparticles in biomedicine is likely to revolutionalize 
future clinical practice due to their ability to cross biological barriers and high drug loading 
capacity [2]. Fig. 2.1 shows various types of nanoparticles [2], ranging from ceramics to 
liposomes. 
 
 
 
 
 
Fig. 2.1. Various types of nanoparticles used in biomedical research and drug delivery. 
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2.1. Cancer 
2.1.1. Etiology of cancer 
Cancer is a disease of the genome. Genomic alterations in critical portions of our 
genome are recognized as being responsible for carcinogenesis. These alterations include the 
activation of oncogenes, genes that stimulate cell growth, or by the inactivation of tumor 
suppressor genes, which ordinarily suppress cell growth [3,4]. To date, more than 100 
oncogenes and 30 tumor suppressor genes have been identified [3]. The etiologies causing 
these mutations in human cancers are classified in Table 2.1.  
 
Table 2.1 – Classification of known or suspected causes of human cancer. 
Type  Examples Responsible carcinogen(s) or pathology Target organ(s) 
Habitual 
Cigarettes 
Alcohol abuse 
Benzo(a)pyrene, dimethylnitrosoamine, etc. 
Ethanol 
Lung, larynx, bladder, kidney, colon, etc. 
Esophagus, liver 
Environmental 
Asbestos 
Radiation 
Drinking water 
Asbestos (local iron overload) 
Radicals  
Arsenic, etc. 
Mesothelium, lung 
Bone marrow (leukemia), thyroid gland 
Skin  
Work-associated 
Asbestos 
Chemical factory 
Asbestos (local iron overload) 
Benzene 
Mesothelium, lung 
Bone marrow (leukemia) 
Diet 
High-fat, low-fiber 
Low-vegetable, high nitrate 
Reactive oxygen species (ROS), lipid 
peroxide? 
Nitrate, N-nitrosamine, etc. 
Bowel, pancreas, prostate, breast 
 
Stomach, esophagus 
Infection 
Helicobacter pylori 
Human papilloma virus 
Hepatitis virus B and C 
 
Cag A, chronic inflammation 
E6, E7 
Autoimmunity-induced  inflammation and 
iron overload 
Stomach 
Uriterine cervix 
Liver 
 
Genetic 
Genetic hemochromatosis 
Li-Fraumeni syndrome 
 
Iron overload 
Early inactivation of tumor suppressor gene 
under normal lifestyle 
Liver 
Lymphoid cells, bone, etc. 
 
Endogenous No special risk recognized Normal oxygen and iron metabolism (ROS) All sorts of organs according with aging 
 
2.1.2.  Type of cancer treatments 
Different forms of cancer treatment are available nowadays such as surgery, 
chemotherapy, radiation therapy, and many others. Cancer treatment options will depend on 
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the cancer type of patient and its stage of development. Cancer treatment may cure the cancer, 
keep cancer from spreading, slow cancer growth, destroy cancer cells that may have spread 
(metastasized) to other parts of the body from the original tumor site, and relieve the 
symptoms caused by cancer. 
 
2.1.2.1. Surgery  
Surgery for treating cancer is the removal of cancerous tissue from the body. It can be 
used to diagnose, treat, or even help prevent cancer in some cases. It often offers the greatest 
chance for cure, especially if the cancer has not spread to other parts of the body.  
 
2.1.2.2. Chemotherapy 
Chemotherapy (chemo) is the use of medicines or anticancer drugs to treat cancer. The 
thought of having chemotherapy frightens many people. Chemotherapy medications can be 
given to you in different ways. The four most common ways to give chemotherapy are by 
vein (intravenously), mouth (orally), injection into muscle (intramuscular), and injection into 
the central nervous system (intrathecal).  
 
2.1.2.3. Radiation therapy 
Radiation therapy uses high-energy particles or waves to destroy or damage cancer cells. 
It is one of the most common treatments for cancer, either by itself or along with other forms 
of treatment. Radiation is able to treat certain areas that sometimes cannot be reached with 
chemotherapy. 
 
2.1.2.4. Other methods 
Targeted therapy, immunotherapy, photodynamic therapy, and stem cell transplant 
(Peripheral Blood, Bone Marrow, and Cord Blood Transplants) also can be an option for 
cancer treatment.  
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2.2. Carbon nanotubes 
2.2.1. Historical background 
Carbon materials influence every aspect of human daily life in some way. These 
materials can be found in variety forms such as graphite, diamond, carbon fibers, fullerenes, 
and carbon nanotubes [5]. Carbon nanotubes (CNTs) themselves become one of the most 
actively investigated structures of the last century due to their unique electronic, mechanical, 
optical and chemical characteristics. A brief review of the history of carbon nanotubes, In 
1991, Iijima presented the presence of elongated and concentric layered microtubules made of 
carbon atoms through a detection of multi-walled carbon nanotubes (MWCNTs) under 
transmission electron microscopy, which, until then, had mostly been considered as 
filamentous carbon [6,7]. Although carbon nanotubes had been observed prior to his 
"invention", it is widely recognized that Iijima's work catapulted carbon nanotubes onto the 
global scientific stage. 
 
 
 
Fig. 2.2. Carbon materials including (a) graphite, (b) diamond, (c) 0D, buckminsterfullerene 
(C60), (d) 1D, nanotube, and (e) 2D, graphene. 
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2.2.2. Synthesis of carbon nanotubes 
This section is devoted to give a brief description of the most established nanotubes 
production routes with primary emphasis on single-wall nanotubes. In Table 2.2 Yang et al. 
have summarized the improved synthetic methods of CNTs which have been published in 
recent years [8].  
 
Table 2.2 – The synthetic methods of CNTs. 
Method Progress Consequence 
Arc discharge Synthesized they between two graphite rods in 
water bath at different voltage 
 
Two graphite electrodes submerged in different 
liquid media 
 
Using strong oxidizing agent HNO3/H2O2 
instead of metal catalyst and vacuum devices 
 
The discharge is maintained in a magnetic field 
Using physical forces both during synthesis 
Good quality and high yield CNTs are 
obtained 
 
Yielding various dimensional nanocarbon 
structures 
 
Improving purity of MWCNTs 
 
 
High quality MWCNTs are obtained 
Relatively straight and defect free MWCNTs 
are obtained 
 
Laser ablation Dynamic light scattering, micro-Raman and 
high-resolution transmission electron 
microscopy were used 
 
Using binary catalysts combining the transition 
metals Fe, Co and Ni 
 
Direct synthesis using pulsed laser ablation 
 
 
Irradiating of a CO2 laser in continuous wave 
mode onto a boron-containing graphite target at 
room temperature 
 
Ablating a nickel/carbon composite target in 
ethanol or ambient air 
 
Controlling their nanostructures 
 
 
 
Different carbon nanostructures can be 
obtained 
 
SWCNTs show fast and strong 
photoresponse (as high as 1350% at 405 nm) 
 
The fine crystalline structure of MWCNTs 
can be obtained 
 
 
MWCNTs 
CVD Growing on iron catalyst film using plasma 
enhanced chemical vapor deposition (PECVD) 
system 
 
Co was used as catalysts, at 700 ºC using 
hydrogen to acetylene gas ratio at 25:25 Sccm 
 
Using NiO powder as catalysts and LPG as 
carbon source 
 
AlPO4 was used as catalysts 
Vertically aligned single wall carbon 
nanotubes of diameter 0.8–1.5 nm can be 
obtained 
 
High yield of MWCNTs 
 
 
The yield of CNTs increased 
 
 
Y-shaped CNTs 
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Taking iron nanoparticles as catalyst 
 
Taking Co–Mo as catalyst and using CH4 at 900 
ºC 
 
Metal catalyst-free mist flow 
 
 
Ni over Cr layer as a catalyst at 600 ºC 
 
Taking Ni/MgO as catalyst and using CH4 in 
micro-fluidized bed 
 
Photochemical deposition 
 
 
SWCNTs 
 
SWCNTs 
 
 
SWCNTs can be synthesized without any 
treatments 
 
CNTs 
 
CNTs exhibited relatively small and mean 
outer diameter, less defect, and high purity 
 
MWCNTs 
Others 
Low-temperature plasma 
 
 
Low-temperature plasma 
reduction 
 
Solvothermal 
 
Low-temperature solvothermal 
 
 
Solvothermal 
 
 
Sol–gel 
 
 
Hydrothermal 
 
 
Hydrothermal 
 
 
Flame 
 
 
 
Flame 
 
 
Flame 
 
 
Flame 
 
The plasma causes the dissociation of carbon 
resource 
 
Facile glow discharge plasma reduction 
operated at room temperature 
 
At the low temperature of 180 ºC 
 
Dichlorobenzene as a carbon source was 
catalyze by a solvothermal approach at 200 ºC 
 
At the temperature of 200 ºC and a reaction for 
10 h 
 
The mixed solution was evaporated at 80 ºC for 
8 h 
 
The solution was transferred into a 100 mL 
autoclave and kept at 160 ºC for 8 h 
 
The solution was transferred into a 30 mL 
autoclave and kept at 150 ºC for 4 h 
 
Diffusion flames were acted as reaction 
environments, using catalysts as aerosols and 
supported upon substrates 
 
CNT growth occurs via the decomposition of 
flame-generated carbon precursors 
 
Using rotating opposed flow ethylene 
diffusion flames and a catalytic Ni substrate 
 
Taking Fe/Mo/Al2O3 as catalyst 
 
CNTs with highly distributed active species 
and catalyst activation 
 
CNTs 
 
 
MWCNTs bundles 
 
Well-aggregated carbon nanotubes are 
achieved 
 
Magnetic MMWCNTs with alterable 
structure 
 
MWCNT–LiMn2O4 
 
 
CNTs with well-dispersed Fe3O4 
 
 
CNT core/porous MnO2 
 
 
CNTs 
 
 
 
CNTs with higher physical properties 
 
 
Controlling the synthesis of CNTs 
 
 
Self-oriented CNTs 
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Fig. 2.3. Schematic representation of methods used for carbon nanotubes synthesis: (a) Arc 
discharge method, (b) chemical vapour deposition method, (c) laser ablation method. 
 
2.2.2.1. Arc discharge 
Schematic diagram of arc-discharge system [9] is shown in Fig. 2.3. It is a simple and 
traditional tool for generating the high temperatures needed for the vaporization of carbon 
atoms into a plasma (>3000ºC) [10–13]. The carbon arc-discharge method is a high 
temperature process that can be used for the production of nanotubes as well as fullerenes. 
The derived product and the yields are mainly dependent on the atmosphere and catalysts 
utilized [7]. Arc discharge method is probably one of the simplest methods for synthesizing 
for both single-walled and multi-walled carbon nanotubes on a large scale. In the carbon arc-
discharge method, an arc is ignited between two graphite electrodes in a gaseous background 
(usually argon/hydrogen). The arcing evaporates the carbon and meanwhile it cools and 
condenses that some of the product forms as filamentous carbon on the cathode. Catalysts 
used to prepare isolated single-wall carbon nanotubes include transition metals such as Co, 
Ni, Fe and rare earths such as Y and Gd, while mixed catalysts such as Fe/Ni, Co/Ni and 
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Co/Pt have been used to synthesize ropes of single-wall nanotubes [10]. The optimization of 
metals being included in the anode led to the growth of single-walled carbon nanotubes [14]. 
 
2.2.2.2. Laser ablation 
In the laser ablation technique, a high power laser is used to vaporize carbon from a 
graphite target at high temperature. Historically the fullerenes synthesized in the pioneering 
work of R.F. Curl, H.W. Kroto, and R.E. Smalley was produced using a laser evaporation 
technique [15]. They directed an intense pulse of laser light on a carbon surface in a stream of 
helium gas. The evaporated material condenses to yield fullerenes. In order to generate 
SWCNTs, metal particles as catalysts must be added to the graphite targets similar to the arc 
discharge technique. The incorporation of a metal catalyst in the carbon target leads to the 
formation of SWCNTs with a narrow diameter distribution and high yields. The SWCNTs 
yield and diameter distribution can be varied by controlling the process parameters in the 
reaction such as the amount and type of catalysts, laser power and wavelength, temperature, 
pressure, type of inert gas, and the fluid dynamics near the carbon target. Schematic diagram 
of the laser ablation apparatus is shown in Fig. 2.3. Both MWCNTs and SWCNTs can be 
produced with this technique.   
 
2.2.2.3. Chemical vapor deposition (CVD) 
Unlike arc discharge and laser ablation methods, chemical vapor deposition technique 
can be classified as the low-temperature method. In principle, chemical vapor deposition can 
be understood as a chemical process in which volatile precursors are used to provide a carbon 
feed source to a catalyst particle or pore at elevated temperatures (350–1000ºC) [7]. The 
growth mechanism is based on the dissociation of carbon containing molecules which is 
catalyzed by a transition metal (typically Ni, Fe or Co). After dissolution in the metal particle, 
a precipitation phenomenon leads to the formation of tubular carbon solids in sp2 structure. 
Materials grown over the catalyst, MWCNTs or SWCNTs, can be obtained as non-ordered 
soot, densely aligned bundles or as individual array deposited on the substrate [16]. Various 
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adaptations of CVD-based methods such as thermochemical CVD (traditional), plasma 
enhanced CVD, aerosol assisted (AA-CVD), aerogel supported, high pressure CO 
disproportionation (HiPCO), alcohol catalytic CVD (AACCVD) in ambient or vacuum base 
pressure, the CoMoCat process, and even a hybrid laser assisted thermal CVD (LCVD) are 
available [7].  
 
2.2.3. Structure of single-walled carbon nanotubes 
 
     
 
Fig. 2.4. (a) Three types of SWCNT: armchair, zigzag, and chiral. (b) The unrolled 
honeycomb lattice of a carbon nanotube. A carbon nanotube can be constructed by connecting 
O with A and B with B’ to form the unit cell for the carbon nanotube which defined as the 
rectangle OAB’B. Vector OA and vector OB represent the chiral vector Ch and the 
translational vector T.  
 
SWCNTs have a cylindrical structure and can be described as a graphene sheet rolled up 
concentrically into a cylindrical shape to form one dimensional structure with a diameter of 
about 0.7–10.0 nm and tube length can be many thousands of times longer [7,10]. 
Terminations of SWCNTs are often called caps or end caps and consist of a “hemisphere” of 
O 
A 
B 
B’ 
θ 
a2 
a1 
Ch = na1 + ma2 ≡ (n, m) 
T 
(n, 0) zigzag 
(n, n) armchair armchair chiral zigzag 
(a) (b) 
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a fullerene which is more unstable than the sidewall tube and make it easy to be removed by 
oxidation process. Based on the different direction of winding, SWCNTs can be categorized 
as armchair, zigzag, and chiral SWCNTs as shown in Fig. 2.4. (a). The structure of SWCNTs 
can be explained by mapping the graphene plane into the cylinder without the deformation of 
hexagon graphene layer as shown in Fig. 2.4. (b). When we roll up the graphene sheet so that 
points O and A coincide, and points B and B’ coincide, a model of a single-walled carbon 
nanotube can be made. This structure of SWCNT is specified by two vectors: vector OA and 
vector OB. Vector OA is the chiral vector Ch which perpendicular to the nanotube axis and 
can be illustrated by the following equation: 
 
                                          (1)          
 
Ch is a linear combination of the lattice basis vectors (a1 and a2), and n and m are positive 
integers which are known as the chiral indices. Meanwhile, vector OB is the translational 
vector T which is parallel to the tube axis and perpendicular to the chiral vector.  
The structure types of SWCNTs are related to their chiral vector (n, m) and the chiral 
angle θ. Chiral angle is the angle between the vectors Ch and a1 and can be determined by: 
 
           
 
    
                              (2)    
 
As shown in Fig. 2.4. (b), in case n = m and chiral angle is equal to 30º, the type of SWCNTs 
is called armchair (n = m, θ = 30º, Ch = (n, n)). When (m = 0, n > 0, θ = 0º, Ch = (n, 0)), the 
type of SWCNTs is called zigzag; and when (n ≠ m, 0 < θ < 30°, Ch = (n, m)), the type of 
SWCNTs is called chiral.       
 
2.3 Carbon nanotubes as drug delivery tools 
Carbon nanotubes (CNTs) are one of nanomaterials which being actively explored by 
researchers, scientists and academicians for the development of new, safe and effective 
nanomedicine including the development of CNTs as a drug delivery tool [17]. In drug 
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delivery, SWCNTs are known to be more efficient than MWCNTs due to its one-dimensional 
structure and ultrahigh surface area for high drug loading capacity [18].    
 
2.3.1. Carcinogenicity of carbon nanotubes 
Carcinogenicity can be defined as the ability or tendency of a substance to produce 
cancer. 
 
2.3.1.1. Carcinogenicity of single-walled carbon nanotubes (SWCNTs) 
To date, the carcinogenicity of SWCNTs has not been reported. The nanoscale size of 
SWCNTs makes this type of carbon material can be taken up by many types of cells and to be 
excreted mainly via the urine [19,20]. However, this issue still must be a concern to be 
investigated further since several papers reported the interactions between SWCNTs and the 
mitotic spindle which may cause genomic alterations [21].  
 
2.3.1.2. Carcinogenicity of multi-walled carbon nanotubes (MWCNTs) 
In contrast with SWCNTs, many papers have reported their research toward this issue. 
Some of them give positive results about the potential toxicity of MWCNTs, while others give 
negative results. Takagi et al. showed that MWCNTs cause malignant mesothelioma in p53 
hetero-knockout mice after intraperitoneal injection [22]. The following report by Sakamoto 
et al. showed that intrascrotal injection of the same MWCNTs in male Fischer 344 rats led to 
mesothelioma [23]. However, in all of these experiments, mesothelial cells were directly 
exposed to MWCNTs, which is not representative of the actual human exposure situation. 
Some aspects such as high exposure dose and very sensitive models use in these research was 
also criticized. Therefore other types of experiments would be necessary to evaluate the 
carcinogenicity of MWCNTs. Other publications showed negative results about this topic. 
Müller reported no increase in carcinogenesis following intraperitoneal injection of MWCNTs 
[24]. Takanashi et al. also reported no increase in carcinogenesis after implanting MWCNTs 
subcutaneously in rasH2 transgenic mice [25]. 
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2.3.2. Functionalization of CNTs 
Despite the advantages of CNTs, there are also some limitations to use pristine CNTs 
directly in biomedicine field. Pristine CNTs is chemically inert, highly hydrophobic, and 
incompatible with almost all organic and inorganic solvents [26,27]. It is also contaminated 
with metal catalysts and amorphous carbons. In order to address these problems, surface 
modifications and functionalization of CNTs can be applied in order to improve their 
physicochemical and surface properties. The main objective of functionalizing CNTs for 
biomedical applications is to increase their solubility or dispersion in aqueous media or 
biocompatible solvents, thereby reducing toxic effects.  Different functionalization strategies 
have been pursued and they can be devided into two main approaches: 
1) Additional reactions to the sidewalls and tips of CNTs and 
2) Oxidation followed by carboxyl based couplings. 
 
2.3.2.1. Covalent functionalization 
Enhancing dispersibility while lowering toxicity of CNTs could be achieved by 
purifying the CNTs by covalent functionalization through multistep acid treatment. During 
the oxidation process, chemical groups such as COOH, OH, and CO are introduced to the side 
walls of CNT that will enhance the solubility of CNTs in aqueous solutions. The carboxylic 
groups also allow for covalent coupling with other molecules through amide and ester bonds. 
Through this method, CNTs can be conjugated with various functional groups such as 
bioactive agents like peptides, proteins, nucleic acids, and therapeutic agents such as anti-
cancer drugs [28].  
 
2.3.2.2. Non-covalent functionalization 
Another method of surface modification of CNTs includes non-covalent 
functionalization. CNTs are known to non-covalently interact with various molecules through 
weak interactions such as surface adsorption onto the side walls of CNTs, π-π stacking, 
electronic interactions, hydrogen bonding, and van der Waals force [26]. This 
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functionalization via this π stacking and/or hydrophobic interactions using aromatic 
compounds, polymers, peptides, proteins, DNA, and surfactants [29] as shown in Fig. 2.5.   
 
 
Fig. 2.5. Non-covalent functionalization of CNTs with small aromatic molecules, surfactants, 
phospholipid-PEG (PL-PEG) derivatives, DNA, proteins, and polymers. 
 
2.3.3. Delivery of anti-cancer drugs  
The effectiveness of cancer treatment needs the proper amounts of drugs to be directed 
to the targeted tissue with minimum unwanted effects of the drugs on normal, healthy tissue. 
Conventional administration of chemotherapeutic agents is often compromised by their 
systemic toxicity due to lack of selectivity. In addition, limited solubility, poor distribution 
among cells, inability of drugs to cross cellular barriers, and especially a lack of clinical 
procedures for overcoming multi-drug resistant cancer, all limit the clinical administration of 
chemotherapeutic agents [30]. Recently, novel SWCNT-based tumor-targeted drug delivery 
systems (DDS) have already been developed by several investigators. These delivery systems 
generally consist of three parts: functionalized SWCNTs, tumor-targeting ligands, and 
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anticancer drugs. When DDS interact with cancer cells, they could recognize cancer-specific 
receptors on the cell surface and then induce receptor-mediated endocytosis. It has been 
demonstrated that the complex was taken up efficiently and specifically by cancer cells with 
subsequent intracellular release of chemotherapeutic agents, which suppressed proliferation of 
cancer cells as illustrated in Fig. 2.6 [31].  
 
 
Fig. 2.6. Schematic example of receptor mediated endocytosis targeted drug delivery via 
parenteral administration of CNTs formulation. 
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Chapter 3 
Purification and acid oxidation methods to yield highly purified 
oxidized single-walled carbon nanotubes 
 
3.1. Introduction 
The role of nanotechnology is gaining importance in biology and medicine field [1–6]. 
A variety of novel nanomaterials such as quantum dots and fullerenes including carbon 
nanotubes (CNTs) are increasingly being investigated for their use in biomedical applications 
and nanomedicine. Carbon nanotubes (CNTs) have attracted the attention of many researchers 
and scientists over the last two decades after the discovery of their presence through a 
detection of multi-walled carbon nanotubes (MWCNTs) under transmission electron 
microscopy by Iijima in 1991 [7]. CNTs have a cylindrical structure and can be categorized as 
single-walled carbon nanotubes (SWCNTs), double-walled carbon nanotubes (DWCNTs), 
and multi-walled carbon nanotubes (MWCNTs). SWCNTs can be described as a graphene 
sheet rolled up concentrically into a cylindrical shape to form one dimensional structure with 
a diameter of about 0.7–10.0 nm and tube length can be many thousands of times longer [8,9]. 
In recent years SWCNTs have been intensively studied and the substantial interests of 
SWCNTs stem from the view point of their unique electronic, mechanical, optical and 
chemical characteristics. Due to their unique properties, SWCNTs become one of the 
promising candidates that enable for a variety of biomedical applications ranging from 
imaging to therapy, such as diagnosis, treatment, imaging, and tissue engineering [9–16]. To 
date, carbon nanotube-based drug carriers have attracted much attention owing to their high 
surface area and large micropore volume that provide a high capacity for drug loading onto 
the surface or within the interior core of carbon nanotubes via both covalent and non-covalent 
interactions [17] and also its capacity to cross biological barrier [18–20]. 
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Nevertheless, there are some major limitations to use pristine SWCNTs directly in 
biomedicine research. Firstly, pristine SWCNTs are hydrophobic which makes it insoluble in 
water and in most biocompatible solvents. Therefore functionalization of its surface using 
covalent or non-covalent modification methods is necessary to increase their dispersibility 
thus allowing their use in biomedicine research. This action will not only enhance their 
dispersibility but also their biocompatibility since the addition of functional groups or coating 
on the surface of CNTs will dramatically change their reactivity and reducing the citotoxicity 
of CNTs, therefore more biocompatible [21–24]. One of the most widely applied methods for 
this purpose is to oxidize the surface of pristine SWCNTs by chemical oxidation using some 
reagents such as nitric acid, sulfuric acid, hydrogen peroxide or potassium permanganate [25–
27]. The obtained functionalized SWCNTs from this oxidative treatment then can be further 
conjugated by different biological or bioactive molecules including drugs, proteins, and 
targeting ligands. Other issues such as the length, diameter, surface area, tendency to 
agglomerate, presence and nature of catalyst residues also must be considered before we used 
CNTs in biomedicine research since these physicochemical characteristics is believed as 
determinants of CNTs toxicity [28]. Some of these properties can be engineered to achieve the 
best possible basis material of CNTs for biomedicine research. 
This study will specifically focus on engineering an establish method of purification and 
oxidation of SWCNTs in order to produce feasible oxidized SWCNTs (Ox-SWCNTs) that are 
essentially free of metals, well dispersed in aqueous solutions, and contain abundant 
carboxylic acid groups functional groups which suitable for use as a starting material in 
biomedicine research involving SWCNTs.   
 
3.2. Experimental 
3.2.1. Material 
The pristine SWCNTs were synthesized by the laser ablation process with Ni and Co as 
catalysts at 1423 K by Drs. Y. Hattori and K. Takahashi of Institute of Research and 
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Innovation. All other chemicals were purchased from Wako Pure Chemical Industries, Ltd. 
(Tokyo, Japan). 
 
3.2.2. Purification and acid oxidation 
Two step processes developed from the literature [29–32] were carried out in order to 
purify and oxidize pristine SWCNTs, firstly using acid (the mixture of concentrated sulfuric 
acid (H2SO4) and nitric acid (HNO3) for method A, and only nitric acid (HNO3) for method 
B), followed by a second oxidation step which consisted of refluxing in hydrogen peroxide 
solution. 
 
3.2.2.1. Sulfuric acid - nitric acid treatment (method A) 
Before the process, SWCNTs were immersed and ultrasonicated in ethanol to 
disentangle the tubes and break up bundles. Subsequently, the mixture was filtered through a 
Millipore system (0.2 μm OmniporeTM filter), washed with distilled water and dried at 353 K, 
which was used as the pristine SWCNTs in this study. The pristine SWCNTs (200 mg) were 
immersed and stirred at room temperature in 200 mL of a mixture of concentrated H2SO4 and 
HNO3 with the volume ratio of 3:1 for 48 h. This dispersion was diluted and filtered through 
the membrane filter with a pore diameter of 0.2 μm. The precipitate was dispersed in 200 mL 
of NaOH (0.1 M) by sonication for 15 minutes afterwards filtered and washed by distilled 
water consecutively to remove oxidation debris then followed by washing with HCl (1 M). 
Finally, the oxidized SWCNTs from this first step were washed by distilled water several 
times until neutral pH was reached and the treated SWCNTs are referred to as “Ox-SWCNTs 
A”. In the second step, the “Ox-SWCNTs A” was dispersed in 200 mL of a mixture of H2O2 
(35%) and HCl (1 M) with volume ratio of 1:1 by ultrasonication for 15 minutes and 
subsequently refluxed for 4 h at 353 K. The dispersion was quenched by addition of 1550 mL 
of water and allowed to stand with stirring for 24 h. The dispersion was filtered over the 
membrane filter with a pore diameter of 0.2 μm and washing sequence with NaOH (0.1 M), 
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HCl (1 M) and water as was done in the first step was repeated. This material henceforth is 
referred to as “Ox-SWCNTs”. 
 
3.2.2.2. Nitric acid treatment (method B) 
The difference between method B and method A lies only in the first stage of the 
oxidation process. Method A using the mixture of concentrated sulfuric acid (H2SO4) and 
nitric acid (HNO3), meanwhile at the method B this step was replaced by refluxing the sample 
of SWCNTs in HNO3 at 353 K for 4 h, 8 h, and 16 h. The other processes were the same. 
 
3.2.3. Characterization of pristine and oxidized SWCNTs 
To evaluate the purity, structure and surface modification on SWCNTs materials, a 
number of different analytical techniques, including Raman spectroscopy, infrared 
spectroscopy, thermogravimetry analysis (TGA), field-emission scanning electron microscopy 
(FE–SEM), transmission electron microscopy (TEM), Boehm’s neutralizing titration and 
determination of pore structures by adsorption of nitrogen at 77 K, were used.  
 
3.2.3.1. Raman spectroscopy 
Both samples, pristine SWCNTs and Ox-SWCNTs, were prepared by placing a small 
quantity of sample on a microscope glass slide. Measurements were performed using a 
JASCO's NRS–3100 series Raman spectrometer with excitation wavelength of 532 nm. 
 
3.2.3.2. Fourier Transform Infrared Spectroscopy (FT–IR) 
The IR spectra to identify the surface functional groups of SWCNTs samples were 
obtained on a JASCO’s 410 series FT–IR spectrometer, having the resolution of 1 cm–1 and 
scan range from 4000 cm
–1
 to 800 cm
–1
 with the KBr pellet method at room temperature.  
 
3.2.3.3. TGA 
TGA analyses were carried out using a Shimadzu DTG–60AH, by heating SWCNTs 
samples to 1273 K at a constant ramping rate of 10 K min
–1
 under flowing air (100 mL min
–1
). 
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3.2.3.4. FE-SEM 
All FE–SEM images were obtained using a JEOL JSM-6330F FE–SEM, operated at an 
accelerating voltage of 5.0 kV. Samples were prepared by placing a small amount of pristine 
SWCNTs or Ox-SWCNTs onto a piece of double-sided adhesive tape stuck to a metal stub.  
 
3.2.3.5. TEM 
The microstructure and morphology of pristine SWCNTs and Ox-SWCNTs were 
analyzed by high transmission electron microscopy a JEOL JEM–2100F HRTEM. Samples 
for TEM were prepared in the ethanol and briefly sonicated in a water bath for dispersion. 
Drops of this suspension then were placed onto a copper TEM grid and dried. 
 
3.2.3.6. Boehm’s titration 
The Ox-SWCNTs were quantitatively analyzed by titration to determine the acidic 
surface functions on its surface referred to Boehm’s neutralizing titration method [33]. Based 
on the different acidities of carboxyl, lactone and phenolic groups, Ox-SWCNTs can react 
with excessive NaOH, Na2CO3 and NaHCO3, and then be titrated with HCl. In a typical 
experiment, SWCNTs samples were added into 10 mL of 0.01 M NaOH, 0.01 M NaHCO3 
and 0.005 M Na2CO3 separately and ultrasonicated for 15 minutes. Sample solutions were 
stirred for 48 h to allow SWCNTs material to equilibrate with the base solution. The mixtures 
were then filtered and the obtained filtrates were titrated by 0.01 M HCl based on acid-base 
titration. The endpoints were monitored potentiometrically using a HORIBA D–51 pH meter.  
 
3.2.3.7. Determination of pore structures 
Pore structures of SWCNTs samples were determined from nitrogen 
adsorption/desorption isotherms measurements at 77 K using AUTOSORB–1 MP 
(Quantachrome Instruments). Prior to measurement, each sample was degassed for 2 h at 423 
K. The specific surface area, SBET, was calculated by applying the Brunauer-Emmett-Teller 
(BET) equation. The Dubinin-Radushkevich (DR) method was used to calculate the 
micropore volumes.  
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3.3. Results and discussion 
Widespread exploitation of single walled carbon nanotubes (SWCNTs) in biomedicine 
research is limited by the issues of metal impurities, poor aqueous dispersibility and high 
aggregation tendency of pristine SWCNTs due to their huge specific surface areas and strong 
van der Waals binding energies. In this study we developed a chemical treatment protocol to 
overcome these limitations by covalently functionalizing SWCNTs with acids. Two step 
oxidation processes were conducted. SWCNTs were oxidized using two different acid-
treatment methods followed by refluxing in hydrogen peroxide solution as illustrated in Fig. 
3.1.  
 
 
Fig. 3.1. Schematic of purification and acid oxidation protocol. 
 
These processes allowed the removal of catalyst impurities that would be later 
confirmed by TGA and also functionalization of SWCNTs with some oxygen-containing 
groups, mainly carboxylic groups which were generated on the surface of SWCNTs. This 
surface modification has rendered SWCNTs dispersible in aqueous environments, and also 
gives the possibility to conjugate different biological or bioactive molecules including drugs, 
proteins, and targeting ligands using amidation or esterification reactions and allowed for 
further investigation in biomedical applications.   
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3.3.1. Dispersibility and purity 
Since pristine SWCNTs are not pure and usually associated with residual growth metal 
catalyst and amorphous carbon as impurities, purification is the first essential step to be 
considered before we use these materials in biomedical research.  
 
 
 
Fig. 3.2. Aqueous dispersion of pristine SWCNTs (A) and Ox-SWCNTs obtained by method 
A in two different concentrations (B and C) and Ox-SWCNTs obtained by method B for 4h, 
8h, and 16h treatment (D, E, and F) after one-month acid oxidation treatment. 
 
Through the developed process of purification and acid oxidation, we obtained the oxidized 
SWCNTs (Ox-SWCNTs) that were essentially free of metals and well dispersed in aqueous 
solutions since the surface of the Ox-SWCNTs contains abundant functional groups which 
allows to form homogeneous and stable dispersion as shown in Fig. 3.2. Oxidation stability 
and impurity metal content of SWCNTs samples, pristine SWCNTs and Ox-SWCNTs, were 
observed by TGA. The results of TGA analysis are summarized in Table 3.1. The data 
confirms that the impurity metal content was reduced by all the two methods. However, it can 
be observed that the metal content of Ox-SWCNTs for method A treated sample is lower 
compared with those of Ox-SWCNTs treated by method B (from 5.94 wt % (pristine 
SWCNTs) to 0.15 wt % for Ox-SWCNTs A2).   
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Fig. 3.3. TGA curves of (a) Ox-SWCNTs samples of method A and (b) Ox-SWCNTs 
samples of method B. 
 
Due to the facts that many transition metals and their oxides play a catalytic role in the 
gasification of carbon materials, reduction of metal content in SWCNTs samples will lead the 
main burning temperature of SWCNTs shifts to a higher temperature as shown in Table 3.1 
and Fig. 3.3.  
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Table 3.1 – Summary of the impurity metal content of SWCNTs samples. 
Type of SWCNTs Metal residues / % 
The main graphitic 
decomposition temp. / K 
Pristine SWCNTs 5.94 679 
Ox-SWCNTs A1 2.69 760 
Ox-SWCNTs A2 0.15 821 
Ox-SWCNTs B2/4h 1.88 818 
Ox-SWCNTs B2/8h 0.71 828 
Ox-SWCNTs B2/16h 0.73 825 
 
 
 
Fig. 3.4. TEM images of (a) the pristine SWCNTs, (b), (c) and (d) the Ox-SWCNTs A2. 
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The effectiveness of two step purification processes represented by method A also was 
proved by TEM images of SWCNTs materials before and after purification (Fig. 3.4). Most 
metal impurities in the pristine SWCNTs included metal impurities enclosed in carbon shells 
[34] were removed, generating void pointed by a white arrow that can be seen in Fig. 3.4c.  
 
3.3.2. Raman spectroscopy 
Raman spectroscopy was used to characterize the structural quality and purity of the 
examined SWCNTs by monitoring the evolution of the intensity ratio between D to G band 
(ID/IG) during the purification and oxidation processes (Fig. 3.5 and Fig. 3.6). Two bands at 
around 1580 denoted as G-band and 1350 cm
-1 
denoted as D-band, which are the 
characteristic bands of the first-order SWCNTs Raman spectra are observed. As illustrated in 
Fig. 3.5, the developed chemical treatment protocol for the preparation of high purity Ox-
SWCNTs demonstrates a highly efficient removal of carbonaceous impurities. All Raman 
spectra are shown in Fig. 3.6 were baseline corrected and normalized to the intensity of G 
band for the accuracy of the comparison. Pristine SWCNTs as the initial materials were found 
to have a low ID/IG ratio, which suggests that it has a small amount of structural defects. After 
conducting the oxidative and purification treatments, changes in the ID/IG ratio to a higher 
value were observed for the Ox-SWCNTs from both method A and B. This increase can be 
caused by new defects induced on SWCNTs structure after acid treatments, amorphous 
carbon left in the sample, and also the introduction of functional groups that lead to the 
appearance of a broad D band. The ID/IG ratios, G-band frequency, and diameter of all 
examined samples are tabulated in Table 3.2.  
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Fig. 3.5. Raman spectra of various SWCNTs samples related to its carbonaceous impurities.  
 
The intermediate result, Ox-SWCNTs A1, has a higher ratio than Ox-SWCNT A2 due 
to a higher quantity of non-carboxylated carbonaceous material left in the sample. This ratio 
then decreased after the second oxidation step, from 0.12 (Ox-SWCNTs A1) to 0.04 (Ox-
SWCNTs2), demonstrates demonstrates the effectiveness of this step to convert the oxidized 
defects on amorphous carbon to carboxylic acid groups which make it easier to remove these 
impurities through conversion of the acid groups to their more soluble sodium salts, by 
treatment with sodium hydroxide. The G-band of Ox-SWCNTs was upshifted significantly by 
about 6 cm
-1
 compared to pristine SWCNTs caused by removing electrons from SWCNTs as 
a result of the introduction of functional groups through the covalently functionalizing of 
SWCNTs with acids [35, 36]. This result is in line with the FTIR analysis which shows the 
presence of functional groups after the oxidation process. The same pattern of results also can 
be seen from method B as we can see Table 3.2.  
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Table 3.2 – Pore structure parameters of SWCNTs samples. 
Type of SWCNTs Diameter (nm) G-band frequency The ID/IG ratio 
Pristine SWCNTs 1.34 1588 0.02 
Ox-SWCNTs A1 1.33 1591 0.12 
Ox-SWCNTs A2 1.33 1594 0.04 
Ox-SWCNTs B1/4h 1.31 1594 0.09 
Ox-SWCNTs B2/4h 1.33 1594 0.04 
Ox-SWCNTs B1/8h 1.34 1597 0.10 
Ox-SWCNTs B2/8h 1.34 1596 0.09 
Ox-SWCNTs B1/16h 1.32 1599 0.17 
Ox-SWCNTs B2/16h 1.32 1597 0.14 
 
Raman analysis also provides information about tube diameter of pristine and Ox-
SWCNTs that can be calculated from the most characteristic Raman active vibrational mode 
of carbon nanotubes, the radial breathing mode (RBM). The RBM results from low-energy 
radial vibrations of carbon atoms in the nanotube backbone and this RBM frequency is 
inversely proportional to the tube diameter according to the equation, dt (nm) = 248 (cm-
1nm)/ωRBM, where dt is the tube diameter in nm and ωRBM is Raman frequency in wave 
numbers  [37]. As shown in Fig. 3.6a, maximum intensities were observed at 185, 186 and 
187 cm
-1
 for pristine SWCNTs, Ox-SWCNTs A1 and Ox-SWCNTs A2 respectively, 
corresponding to accumulated diameters at 1.34, 1.33 and 1.33 nm. The same calculation was 
applied to Ox-SWCNTs samples from method B and the results can be seen in Table 3.2.  
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Fig. 3.6. Various Raman spectra of SWCNTs samples from (a) method A and (b) method B. 
The inset of figure shows a blue shift of G-band.   
 
3.3.3. Infrared spectroscopy and Boehm titration 
In order to characterize the functional groups on the SWCNTs surfaces after oxidation 
qualitatively and quantitatively, infrared spectroscopy and Boehm titration were used. The 
FTIR spectra as shown in Fig. 3.7 indicate the presence of some significantly apparent bands 
of the Ox-SWCNTs obtained from both methods compared to pristine SWCNTs.  
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Fig. 3.7. FTIR spectra of the examined SWCNTs samples (a) Ox-SWCNTs from method A, 
(b) Ox-SWCNTs from method B.   
 
The sharp peak at ~3230 to 3400 cm
-1 
and ~1400 cm
-1
, are assigned to stretching of –OH 
from carboxylic groups (–COOH and –COH). The bands at the interval of ~1710 to 1734 cm-1 
are C=O stretching in carboxylic acid groups. The bands at ~1500 to 1600 cm
-1 
are associated 
to conjugation of C=O with C=C bonds or interaction between localized C=C bonds and 
carboxylic acids. The band at ~1110 cm
-1
 is associated to C–O stretching of alcoholic 
compounds. Based on these results, the existence of different groups on the surfaces of the 
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Ox-SWCNTs, mainly carboxylic acid groups, were proved indicating the successful of our 
developed method to oxidize the SWCNTs sample.   
 
 
Fig. 3.8. Acid-base titration profile and its first-order derivative of Ox-SWCNTs samples 
from method A. 
 
Table 3.3 – Surface chemistry of the oxidized SWCNTs samples. 
Functional groups 
Total acidic functional 
groups / mmol g
-1
 
Carboxylic / 
mmol g
-1
 
Lactone / 
mmol g
-1 
Phenolic / 
mmol g
-1 
Pristine SWCNTs 0 0 0 0 
Ox-SWCNTs A1 2.33 1.02 0.65 0.66 
Ox-SWCNTs A2 2.17 1.42 0.12 0.63 
Ox-SWCNTs B2/4h - 1.03 - - 
Ox-SWCNTs B1/8h - 0.81 - - 
Ox-SWCNTs B2/8h - 1.69 - - 
Ox-SWCNTs B2/16h - 2.00 - - 
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Surface chemistry of the Ox-SWCNTs was determined was determined by Boehm’s 
neutralizing titration method, and the result confirms that defects are mainly converted to 
functionalizable carboxylic acid groups. The results of Boehm’s titration in Table 3.3 imply 
that two step oxidation processes in this study give more quantitative conversion of the 
oxidized defects to carboxylic acid groups compared to a conventional single step oxidation 
which only use H2SO4/HNO3 mixture represented by Ox-SWCNTs A1 or only HNO3 
represented by Ox-SWCNTs B1/8h.  
 
3.3.4. Packing density and porosity 
The effects of two step oxidation processes on changes of the packing density and 
porosity of SWCNTs were investigated by field-emission scanning electron microscopy (FE–
SEM) and N2 adsorption/desorption isotherms measurements at 77 K. Morphologies of the 
pristine and Ox-SWCNTs during the oxidation process can be seen in Fig. 3.9. Ox-SWCNTs 
A1 which was HNO3/H2SO4-treated sample has a denser packing density which contributed to 
a larger micropore volume of Ox-SWCNTs A1 as confirmed by gas adsorption results 
summarized in Table 3.4. Fig. 3.10 shows N2 adsorption isotherms of SWCNTs samples from 
method A. Ox-SWCNTs A1 was close to type I of IUPAC classification with predominant 
uptake of N2 at a relative pressure (P/Po) lower than 0.1 although it also has mesopores. On 
the other hand, pristine SWCNTs gave a type II of the adsorption profile due to a predominant 
uptake of N2 at moderate and high P/Po indicating a larger volume of mesopores. Similar 
results have been reported in the literature [29, 30]. The second stage of the oxidation process 
that we have developed in this study changed the packing density and porosity of the Ox-
SWCNTs A1. H2O2/HCl treatment caused an increase in mesoporosity while decreased the 
microporosity of the Ox-SWCNTs A1 as shown by the obtained N2 adsorption profile of the 
Ox-SWCNTs. Morphology of the Ox-SWCNTs A2 was found to have a very low packing 
density as shown in Fig. 3.9c, making it easier to be dispersed in the aqueous solution due to 
the weak interbundle interactions of the Ox-SWCNTs sample. 
38 | P a g e  
 
 
 
Fig. 3.9. FE–SEM images of SWCNTs samples.   
 
The effect of reaction time in nitric acid oxidation of SWCNTs on packing density and 
porosity of the resulted Ox-SWCNTs from method B can be seen in Fig. 3.9 and Table 3.5.  A 
longer duration of oxidation time decrease the packing density that leads to increased 
mesoporosity and decreased microporosity as represented by Ox-SWCNTs B1/4h, Ox-
SWCNTs B1/8h and Ox-SWCNTs B1/16h. Second stage of the oxidation using hydrogen 
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peroxide/HCl solution which also applied in method B gave the same effect on the Ox-
SWCNTs as it does in method A. It caused an increase in mesoporosity while decreased the 
microporosity as shown by the obtained N2 adsorption profile (Fig. 3.11) of the Ox-SWCNTs 
B2/4h, Ox-SWCNTs B2/8h and Ox-SWCNTs B2/16h.  
 
Table 3.4 – Pore structure parameters of SWCNTs samples from method A. 
Parameter Pristine SWCNTs Ox SWCNTs A1 Ox-SWCNTs A2 
Specific surface area  
(BET)/m
2 
g
-1
 (0.01 - 0.05) 
407  727  170  
Specific surface area  
(BET)/m
2
 g
-1
 (0.05 - 0.35) 
377  641  224  
Total pore volume/cm
3
 g
-1
 0.59  0.44  0.51  
Micropore volume (DR)/cm
3
 g
-1
 0.17  0.28  0.07  
Mesopore volume/cm
3
 g
-1
 0.42  0.16  0.44  
 
 
Fig. 3.10. N2 adsorption isotherms of SWCNTs samples from method A at 77 K. Solid and 
open symbols represent the adsorption (A) and desorption (D) respectively.  
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Table 3.5 – Pore structure parameters of SWCNTs samples from method B. 
Parameter 
Pristine 
SWCNTs 
Ox-SWCNTs 
B1/4h B2/4h B1/8h B2/8h B1/16h B2/16h 
Specific surface area 
(BET) /m
2 
g
-1
 (0.01 - 0.05) 
407  823  455  588  371  272  218  
Specific surface area 
(BET) /m
2
 g
-1
 (0.05 - 0.35) 
377  701  431  546  367  303  262  
Total pore volume 
/cm
3
 g
-1
 
0.59  0.44  0.38  0.40  0.31  0.51  0.63  
Micropore volume (DR) 
/cm
3
 g
-1
 
0.17  0.32  0.18  023  0.15  0.11  0.09  
Mesopore volume 
/cm
3
 g
-1
 
0.42  0.12  0.20  0.17  0.16  0.40  0.54  
 
  
 
Fig. 3.11. N2 adsorption isotherms of SWCNTs samples from method B at 77 K. Solid and 
open symbols represent the adsorption (A) and desorption (D) respectively.  
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3.4. Conclusions 
Through the developed protocol of purification and acid oxidation, we obtained the high 
purity Ox-SWCNTs that were essentially free of metals. The Ox-SWCNTs also well 
dispersed in aqueous solutions and defects are effectively converted to functionalisable 
carboxylic acid groups. Moreover, these carboxylic acid groups can be used as conjugating 
sites for different biological or bioactive molecules including drugs, proteins, and targeting 
ligands for a variety of biomedical research purposes. The results also show that the second 
stage of the oxidation process that we have developed in this study changed the packing 
density of the resulted Ox-SWCNTs becomes lower compared to the Ox-SWCNTs from a 
conventional single step acid oxidation method. 
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Chapter 4 
Systematic sorption studies of camptothecin on oxidized single-
walled carbon nanotubes 
 
4.1. Introduction 
Camptothecin (CPT) is a potent anticancer agent which acts against a broad spectrum of 
cancers through the inhibition of DNA enzyme topoisomerase I (topo I) [1]. CPT was first 
isolated by Monroe E. Wall and Mansukh C. Wani in 1958 from extracts of Camptotheca 
acuminate, a tree native to China and Tibet, that has been used as a cancer treatment in 
traditional Chinese medicine [2]. However, even though CPT shows a remarkable activity as 
an anticancer agent, clinical application and therapeutic potential of this agent is limited by its 
insolubility in most biocompatible solvents and also high adverse drug reaction [3, 4].  
 
 
 
Fig. 4.1. The structure of CPT. 
 
Because of these disadvantages, water-soluble analogues of CPT such as topotecan and 
irinotecan are being used clinically for cancer treatment instead of CPT [5] and many others 
of CPT analogues are also under investigation [6–8]. In an effort to achieve the approval to 
apply this promising anticancer agent for clinical use, the insolubility should be improved 
firstly before CPT can be applied as an efficient anticancer drug [9]. To overcome this 
obstacle, synthesis of CPT analogues and development of nanocarrier as a drug delivery 
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system for CPT are mostly done. Various types of nanoparticles currently have been 
investigated and developed as a drug delivery system for CPT, including CPT 
nanosuspensions [10], perfluorocarbon nanoemulsions [11], silica nanoparticles [12], 
dendrimers [13], nanofibers [14], cyclodextrins [15] nanographene [16] and multi-walled 
carbon nanotubes [17]. 
The interaction of SWCNTs with numerous therapeutics including drug molecules and 
biomolecules based on adsorption process is much explored now, providing exciting and new 
opportunities for the future clinical practice [18]. Loading CPT on SWCNTs through the 
adsorption is one of the applied techniques which can be developed as a strategy to overcome 
the insolubility and also improve the efficacy while decreasing the adverse side effects of 
CPT. In the present study I systematically evaluated the fundamental platforms of the 
interaction between CPT and the Ox-SWCNTs with the purpose to explore the potentialities 
of SWCNTs to be developed as an efficient and more suitable nanocarrier for CPT. These 
comprehensive results are expected to motivate further and extensive research toward this 
goal.  
 
4.2. Experimental 
4.2.1. Material 
The Ox-SWCNTs were synthesized by two step processes of purification and oxidation 
method using the mixture of concentrated sulfuric acid (H2SO4) and nitric acid (HNO3) as 
presented in chapter 3 (method A). Camptotechin and all other chemicals were purchased 
from Wako Pure Chemical Industries, Ltd. (Tokyo, Japan). 
 
4.2.2. Fluorescence quenching study 
A decrease in the fluorescence intensity of CPT was observed systematically after 
quenching by the addition of Ox-SWCNTs. CPT and Ox-SWCNTs were mixed in the mixture 
of water and DMSO (65:35), shaken for 48 h at 298 K. Concentrations of CPT were fixed at 
2.16 mg L
–1
 whereas the concentrations of Ox-SWCNTs were varied from 0 to 20 mg L
–1
. 
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The fluorescence quenching samples were then diluted by the solution of water and DMSO 
(90:10) and the fluorescence intensity of these samples before and after filtration through the 
membrane filter with a pore diameter of 0.2 μm were analyzed using JASCO FP-8300 
fluorescence spectrophotometer at an excitation wavelength of 370 nm, the maximum 
absorbance (λmax) of CPT. 
 
4.2.3. Adsorption experiments 
4.2.3.1. The equilibrium sorption and isotherms studies 
The equilibrium sorption of CPT on Ox-SWCNTs was carried out by mixing CPT and 
Ox-SWCNTs in the mixture of water and DMSO (65:35), shaken for 48 h at 298 K. Initial 
concentrations of CPT were varied from 3.78 to 35.80 mg L
–1
 whereas the concentrations of 
Ox-SWCNTs were fixed. The mixtures were diluted by the solution of water and DMSO 
(90:10) then analyzed using JASCO FP–8300 fluorescence spectrophotometer at an excitation 
wavelength of 370 nm. The amounts of CPT adsorbed by the Ox-SWCNTs were calculated 
by the mass balance equation: 
 
   
        
 
 (1)                                                                            
 
where Qe is the amount of CPT adsorbed per gram of Ox-SWCNTs at equilibrium (mg g
–1
), 
C0 is the initial concentration of CPT (mg L
–1
), Ce is the equilibrium concentration of CPT 
(mg L
–1
), m is the mass of Ox-SWCNTs (g) and V is the volume of solution (L). The 
adsorption isotherm models, Langmuir and Freundlich models were used to fit the equilibrium 
isotherm data.  
 
4.2.3.2. Effect of temperature on adsorption and thermodynamics studies 
To observe the effect of temperature to the adsorption process, the same experimental 
procedure for fluorescence quenching study was carried out at three different temperatures; 
298, 308 and 318 K in a thermostatic water bath shaker for 48 h.  
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4.2.3.3. Kinetics study 
Adsorption kinetic experiments were performed in batch adsorption experiment, by 
fixing temperature and shaking rate. Ox-SWCNTs were mixed with CPT in the mixture of 
water and DMSO (65:35), shaken at 298 K.  The initial concentrations were 3.78 mg L
–1
 and 
22.7 mg L
–1
 of CPT and 22.5 mg L
–1
 of Ox-SWCNTs. At given time intervals, the evolution 
over time of CPT concentration in the bulk phase along the experiment time was analyzed 
using JASCO FP-8300 fluorescence spectrophotometer at an excitation wavelength of 370 
nm. The amounts of CPT adsorbed by the Ox-SWCNTs were calculated by the mass balance 
equation. The pseudo first-order, pseudo second-order and Weber-Morris kinetics models 
were employed to investigate the kinetics of adsorption CPT on Ox-SWCNTs.  
 
4.2.4. Statistical analysis 
All the data are presented in this article as mean result ± standard error from three 
independent experiments. Statistical differences were evaluated using t test and P<0.05 was 
considered to be statistically significant. 
 
4.3. Results and discussion 
4.3.1. Fluorescence quenching study 
The maximum fluorescence emission wavelength of CPT was found at 440 nm when the 
excitation wavelength was fixed at 370 nm. As shown in Fig. 4.2a, fluorescence quenching 
effect of the Ox-SWCNTs on CPT, which is indicative of the interactions between CPT and 
the Ox-SWCNTs, was observed during this study. Fluorescence intensity of CPT was found 
to decrease gradually with increasing concentrations of the Ox-SWCNTs. Such a kind of 
quenching can be a result of many molecular interactions including molecule rearrangement, 
ground-state compound formation, excited-state reaction, collision quenching and resonance 
energy transfer [19-21]. To investigate the strength and more specific quenching mechanism 
of CPT by the Ox-SWCNTs, quenching data was analyzed by the following Stern-Volmer 
equation: 
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          (2)                                                                            
 
where F0 and F are respectively the fluorescence intensity of CPT in the absence and presence 
of Ox-SWCNTs, [Q] is the concentration of Ox-SWCNTs as a quencher (g L
-1
) and KSV is the 
Stern-Volmer quenching constant (L g
-1
). Concentration of CPT for fluorescence quenching 
study was set lower than the Ox-SWCNTs concentrations to avoid the saturation of CPT 
adsorbed on the Ox SWCNTs that can create a bias to the results.  
 
 
 
Fig. 4.2. (a) Fluorescence quenching spectra of CPT at different concentrations of Ox-
SWCNTs (b) Stern-Volmer plots of CPT with different concentrations of the Ox-SWCNTs 
based on a temperature-variation study. 
 
The Stern-Volmer plot was found to be linear indicating the occurrence of a single 
quenching mechanism, static or dynamic quenching. To understand more about this 
quenching mechanism, temperature effects to the adsorption process of CPT on Ox-SWCNTs 
was observed. The Stern-Volmer plots of CPT with different concentrations of Ox-SWCNTs 
based on a temperature-variation study in Fig. 4.2b shows that a decrease in the adsorption of 
CPT on the Ox-SWCNTs is corresponding to an increase in temperature. A good linear 
relationship between F0/F and [Q] was obtained from this temperature dependency studies, 
and the Stern-Volmer quenching constant decreased as temperature increased; 26.6, 18.1 and 
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10.3 L g
-1
 respectively. These results suggest that the fluorescence quenching mainly arises 
from static quenching mechanism due to the formation of non-fluorescent complex between 
Ox-SWCNTs and CPT. It is based on fact that complex formation strength is inversely 
proportional to temperature, higher temperature will dissociate weakly bound complexes, and 
hence static quenching tends to be higher at lower temperatures. The formation of non-
fluorescent complex of CPT and Ox-SWCNTs was also shown by the fluorescence intensity 
of the adsorption samples before and after filtration process through the membrane filter as 
summarized in Table 4.1.  
 
Table 4.1 – Evidence of the decrease in fluorescence intensity due to complex formation of 
CPT–Ox-SWCNTs.    
Initial 
[CPT] / 
mg L
-1
 
[Ox-SWCNTs A]  
/ mg L
-1
 
Fluorescence 
intensity 
by filtration 
Fluorescence 
intensity 
without filtration 
P value 
(t test) 
Assignment 
 
3.78 22.5 131 ± 3 133 ± 1 0.41 
P value > 0.05  
the averages are 
not significantly 
different 
 
18.90 22.5 852 ± 18 824 ± 11 0.14  
26.46 22.5 1125 ± 29 1139 ± 18 0.36  
35.80 22.5 1440 ± 29 1431 ± 23 0.32  
 
The results show that no statistically significant differences were present. From these 
data we conclude the fluorescence intensity is derived only from free CPT and the adsorbed 
CPT on Ox-SWCNTs has no contribution to the fluorescence intensity. Therefore we can 
rearrange the Stern-Volmer equation (Eq. 2) becomes: 
 
  
 
         (3)                                                                            
 
where Ks is the association constant for the complex formation [21]. 
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4.3.2. Effect of temperature on adsorption and thermodynamics studies 
The adsorption experiments at different temperature were performed to evaluate the 
influence of temperature on the adsorption mechanism and it was demonstrated that the 
adsorption was affected by temperature. Thermodynamic parameters such as changes in 
Gibbs free energy (ΔGº), enthalpy (ΔHº), and entropy (ΔSº) were evaluated in order to get 
information of the energetic changes that is associated with the adsorption mechanism of CPT 
on Ox-SWCNTs by using the following equations: 
 
     
   
 
 
   
  
             (4)         
                                                                    
                                              (5)       
                                                                      
    
       
 
 (6)                                                                            
 
 
Fig. 4.3. van’t Hoff plot for the adsorption of CPT on Ox-SWCNTs. 
 
A value of ΔHº was calculated from the slope of plot between ln Ks versus 1/T, as 
shown in Fig. 4.3. Referring to the thermodynamic parameters which are listed in Table 4.2, 
the negative ΔHº indicates that the adsorption of CPT on Ox-SWCNTs in this particular 
condition is an exothermic process. The negative value of ΔGº at all of temperatures denotes 
that the adsorption of CPT by Ox-SWCNTs is spontaneous and thermodynamically favorable. 
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Furthermore, a more negative value of ΔGº along with temperature decrease implies that the 
performance of CPT adsorbed on the Ox-SWCNTs is more favorable at lower temperatures. 
Finally, from the thermodynamic aspects, it can be deduced that the adsorption of CPT on the 
Ox-SWCNTs is physical adsorption. 
 
Table 4.2 – Thermodynamic parameters of CPT adsorption on Ox-SWCNTs. 
Temperature / K ln Ks ΔHº / kJ mol-1 ΔGº / kJ mol-1 ΔSº / J mol-1 K-1 
298 3.28 
-37.3 
-8.13 -97.8 
308 2.90 -7.42 -96.9 
318 2.33 -6.17 -97.8 
 
 
4.3.3. The equilibrium sorption and isotherms studies 
 
 
Fig. 4.4. Time course of CPT adsorption on Ox-SWCNTs with two different initial CPT 
concentrations. 
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Table 4.3 – Effect of contact time and initial CPT concentration on CPT sorption onto Ox-
SWCNT. 
Conc. of CPT (mg L
-1
) 
Conc. of  Ox-SWCNT 
(mg L
-1
) 
CPT loading capacity of Ox-SWCNT 
(mg gr
-1
) 
3.78 22.5 78.11 ± 2.30 
7.56 22.5 124.67 ± 12.60 
11.34 22.5 196.66 ± 24.18 
15.12 22.5 229.87 ± 29.81 
18.90 22.5 318.88 ± 25.08 
22.68 22.5 370.56 ± 61.70 
26.46 22.5 394.99 ± 36.95 
28.64 22.5 396.61 ± 15.17 
32.22 22.5 372.12 ± 8.16 
35.80 22.5 410.66 ± 35.54 
 
The adsorption of CPT on Ox-SWCNTs was found to reach equilibrium within 24 hours 
as we can see in Fig. 4.4. This moderate rate process could prevent the loss of CPT bioactivity 
during the process. The effect of the initial CPT concentration on CPT sorption represented by 
two different concentrations also can be seen in Fig. 4.4. Initially, the adsorption of CPT was 
found to be rapid in the first 3 h (180 min) due to a higher availability of active sites on the 
surface of Ox-SWCNTs and then became slower along with the increasing of contact time, 
before reaching equilibrium. It also can be seen that the initial concentration allowed a greater 
driving force to overcome the mass transfer resistances between the aqueous and solid phases 
of CPT leading to increase of equilibrium adsorption capacity. However, based on the results 
as shown in Fig. 4.5 and Table 4.3, increase in equilibrium adsorption capacity seems to stall 
due to saturation when the initial concentration of CPT was higher than 26.5 mg L
-1
. Over this 
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concentration the equilibrium adsorption capacity reached equilibrium values which were 
constant at approximately 400 mg g
-1
. 
 
 
Fig. 4.5. Adsorption isotherms of CPT on the Ox-SWCNTs.  Fitting curves were obtained 
based on the two models in Fig. 4.6.  Green: Langmuir-type model, Red: Freundlich-type 
model. 
 
The adsorption isotherm was analyzed using the most common adsorption isotherm 
models, Langmuir-type and Freundlich-type models to fit the equilibrium isotherm data in 
order to describe the distribution of CPT between adsorbent and solution in the equilibrium 
state. Langmuir adsorption parameters were determined by the linear form of Langmuir 
equation: 
 
 
  
 
 
  
 
 
      
 (7)                                                                            
 
where Ce is the equilibrium concentration of CPT (mg L
-1
), Qe is the amount of CPT adsorbed 
per gram of Ox-SWCNTs at equilibrium (mg g
-1
), Qo is the maximum monolayer coverage 
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capacity (mg g
-1
), and KL is the Langmuir isotherm constant (L mg
-1
). Freundlich adsorption 
parameters were also determined by its linear form equation: 
 
            
 
 
      (8)                                                                            
 
where Ce is the equilibrium concentration of CPT (mg L
-1
), Qe is the amount of CPT adsorbed 
per gram of Ox-SWCNTs at equilibrium (mg g
-1
), Kf is the Freundlich isotherm constant( (mg 
g
-1
)(L mg
−1
)
1/n
) and n is the Freundlich exponent factor. The comparing plots of the theoretical 
Langmuir and Freundlich isotherms with the experimental data of adsorption CPT on Ox-
SWCNTs are shown in Fig. 4.6. The calculated Langmuir and Freundlich parameters and 
related coefficients are listed in Table 4.4.  
 
 
Fig. 4,6. Analyses on adsorption isotherms based on two models for the adsorption of CPT on 
the Ox-SWCNTs: (a) Langmuir-type model, (b) Freundlich-type model.  
 
As we can see from the results, the Langmuir-type model yielded better fit with higher 
R
2 
value compared to the Freundlich-type model. The Langmuir-type model assumes the 
adsorption occurs at the specific homogeneous sites within the adsorbent and all of these sites 
are equivalent and can accommodate only one adsorbate molecule. The Langmuir-type model 
also assumes that there are no interactions between adsorbate molecules on adjacent sites. 
Theoretical amount of CPT at complete monolayer coverage (Qo) based on the Langmuir-type 
model was 645 (mg g
-1
) which can be defined as the maximum adsorption capacity of the Ox-
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SWCNTs as the adsorbent. The essential parameter of Langmuir model is equilibrium 
parameter, RL, which indicates whether the adsorption is unfavorable (RL > 1), linear (RL = 1), 
favorable (0 < RL < 1) or irreversible (RL = 0) can be defined by the following equation: 
 
   
 
        
 (9)                                                                            
 
where KL is the Langmuir isotherm constant (L mg
-1
) and C0 is the initial concentration of 
CPT (mg L
-1
). In this study, RL values for CPT adsorption over Ox-SWCNTs were less than 
one but greater than zero, indicating a favorable adsorption. From the plot of log Qe versus 
log Ce of Freundlich model we obtained Freundlich exponent factor (n) of 1.47 which reflects 
how favorable the adsorption of CPT is. The value of n lies in the range of 1 to 10 confirms 
the favorable condition for the adsorption. 
 
Table 4.4 – Langmuir and Freundlich isotherm constants for the adsorption of CPT on Ox-
SWCNTs. 
Langmuir  Freundlich 
Qo / mg g
-1
 KL / L mg
-1
 RL R
2
  n Kf  / (mg g
-1
)(L mg
−1
)
1/n
 R
2
 
645 ± 68 0.07 0.31-0.81 0.97  1.47 50.6 ± 3.2 0.95 
 
 
4.3.4. Kinetics study 
Adsorption kinetic which holds the reins of the adsorbate uptake rate and is also 
representing the adsorption efficiency of the adsorbent is expected to provide information 
about the underlying mechanisms of the adsorption and also the optimum conditions for a 
pilot-scale process. In the present study, the experimental kinetic data described in Fig. 4.4 
were analyzed using pseudo first-order, pseudo second-order and Weber-Morris kinetic 
models [22, 23]. 
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Fig. 4.7. Linear regressions of kinetics plot: (a) pseudo first-order model and (b) pseudo 
second-order model of CPT sorption on Ox-SWCNTs with two different initial CPT 
concentrations. 
 
The pseudo first-order kinetic model is expressed by the following equation: 
 
                                                (10a)      
                                                                       
                   (10b) 
 
where qt is the amount of CPT adsorbed at time t (mg g
-1
), qe is the amount of CPT adsorbed 
at equilibrium (mg g
-1
) and k1 is the pseudo first-order rate constant (min
-1
). The plot for the 
model is shown in Fig. 4.7a.  The pseudo second-order kinetic model is expressed as:  
 
        
 
     
   (11a)  
 
 
  
 
 
    
  
 
  
 (11b)                                                                            
 
where qt is the amount of CPT adsorbed at time t (mg g
-1
), qe is the amount of CPT adsorbed 
at equilibrium (mg g
-1
) and k2 is the pseudo second-order rate constant (g mg
-1
 min
-1
). The 
plot for the model is shown in Fig. 4.7b. The kinetic parameters calculated from these models 
and the correlation coefficients R
 
are listed in Table 4.5. A comparison of the kinetic models 
and the overall adsorption capacity was well described by the pseudo second-order kinetic 
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model better than the pseudo first-order kinetic model. The correlation coefficients for both of 
initial CPT concentrations of the pseudo-second order kinetic model show relatively high 
values (>0.999). Additionally, the results also show a good conformity between the 
experimental amount of CPT adsorbed at equilibrium (qe,exp) and the calculated values (qe,cal) 
of the pseudo-second order model. On the other hand, the correlation coefficients obtained 
from the pseudo-first order model were much lower than 0.999 and there was also a 
significant difference between the experimental and calculated qe values of this model. These 
results are indicating that the pseudo-first order kinetic model is not in conformity with 
adsorption kinetics of CPT onto Ox-SWCNTs.  
 
Table 4.5 – Kinetic parameters for the adsorption of CPT on Ox-SWCNTs with different 
concentrations of CPT (concentration of Ox-SWCNTs: 22.5 mg L
-1
; temperature 298 K). 
C0
a
 qe,exp
b
 
Pseudo first-order  Pseudo second-order 
k1
c
 qe,cal
b
 R  k2
d
 qe,cal
b
 R 
3.78 41.6 2.8 x 10
-3
 16.0 0.869  5.88 x 10
-4 
 41.0 0.999 
22.7 364 3.7 x 10
-3 
 89.9 0.797  1.21 x 10
-4 
 370 0.999 
 
  
      
Weber-Morris 
C0
a
 kd1
e
 C1 R1 kd2
e
 C2 R2 kd3
e
 C3 R3 
3.78 3.18  1.41  0.991 0.28 31.1 0.994 0.06 39.3 0.925 
22.7 31.9  0.35  0.999  1.63 307 0.816 0.22 352 1 
*a
 (mg L
-1
)   
b
 (mg g
-1
)   
c
 (min
-1
)   
d
 (g mg
-1
 min
-1
)   
e
 (mg g
-1
 min
-1/2
) 
 
A comparison between four pseudo second-order kinetic linear equations also was examined. 
To assess which linear form is the best-fit kinetic equation, the error distribution between the 
calculated and experimental (qe,cal and  qe,exp) values was compared. Table 4.6 shows the 
calculated kinetic constants and the corresponding error values of these expression forms of 
60 | P a g e  
 
pseudo second-order model. It can be seen that a theoretical pseudo second-order model type 
1 was found representing well the experimental kinetic data of CPT on Ox-SWCNTs.    
 
Table 4.6 – Pseudo second-order kinetic parameters for sorption of CPT on Ox-SWCNTs 
obtained by using the linear methods. 
Type Linear form Parameter 
Initial CPT conc. 
3.78 mg L
-1
 
Initial CPT conc. 
22.7 mg L
-1
 
Type 1 
 
  
 
 
     
 
 
  
 
qe,exp / mg g
-1 41.6 364  
qe,cal / mg g
-1 41  370  
k2 / g mg
-1
 min
-1 5.88 x 10
-4
 1.21 x 10
-4
 
R 0.999  0.999  
Type 2 
 
  
 
 
     
 
 
 
 
  
 
qe,exp / mg g
-1 41.6 364 
qe,cal / mg g
-1 47.9  385  
k2 / g mg
-1
 min
-1 2.83 x 10
-4
 0.75 x 10
-4
 
R 0.981  0.985  
Type 3        
 
     
 
  
 
 
qe,exp / mg g
-1 41.6 364 
qe,cal / mg g
-1 43.3  383  
k2 / g mg
-1
 min
-1 4.33 x 10
-4
 0.82 x 10
-4
 
R 0.893  0.949  
Type 4 
  
 
     
      
    
qe,exp / mg g
-1 41.6 364 
qe,cal / mg g
-1 46.5  392  
k2 / g mg
-1
 min
-1 3.21 x 10
-4
 0.72 x 10
-4
 
R 0.893  0.949  
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The following equation of Weber-Morris kinetic model was used in order to identify the 
diffusion mechanism during adsorption process: 
 
      
 
     (12)                                                                            
 
where qt is the amount of CPT adsorbed at time t, kd is the intra-particle diffusion rate 
constant (mg g
-1
 min
-1/2
) and C is the intercept which is related to the thickness of boundary 
layer. The calculated parameters from the Weber-Morris kinetic model show that the 
adsorption process of CPT on Ox-SWCNTs is quite complex. The value of C which is not 
equal to zero suggests that the intra-particle diffusion is not the rate-determining step and the 
adsorption process involve both intra-particle diffusion and surface diffusion. As shown in 
Fig. 4.8a and Fig. 4.8b, the plot of qt to t
1/2 
exhibits multi linearity with different slopes. The 
first linear part is representing the fastest adsorption stage due to the boundary layer diffusion 
effect. The second linear part is attributed to the diffusion in the liquid contained in the pores 
and along the pore walls which is referred to as the intra-particle diffusion. The last linear part 
is the final equilibrium stage, where the rate of the intra-particle diffusion starts to slow down. 
This result is consistent with the adsorption of other molecules on CNTs [24, 25].  
 
 
Fig. 4.8. Weber-Morris kinetic plots for the adsorption of CPT on Ox-SWCNTs with the 
initial CPT concentration of (a) 3.78 mg L
-1
 and (b) 22.7 mg L
-1
.  
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Fig. 4.9. Diagrammatic illustration of adsorption sites on single-walled carbon nanotube 
bundles. 
 
The possible adsorbed patterns of CPT on Ox-SWCNTs in this solvent system can be on 
individual Ox-SWCNTs and Ox-SWCNTs bundles. For the adsorption on the individual Ox-
SWCNTs and Ox-SWCNTs bundles, CPT would adsorb onto Ox-SWCNTs predominantly 
along the external surface of Ox-SWCNTs. Based on the result from the Weber-Morris 
kinetic model, this type of adsorption is representing the fastest adsorption stage due to the 
boundary layer diffusion effect and gives the highest contribution to the overall adsorption 
amount of CPT on Ox-SWCNTs. In addition to the adsorption process on the external surface, 
for the Ox-SWCNTs bundles the adsorption also might occurred on another site of the Ox-
SWCNTs bundles as shown in Fig. 4.9. The adsorption of CPT is possible on the groove sites 
which are formed by the contact between the adjacent tubes on the external surface of Ox-
SWCNTs bundles. Other sites, hollow and interstitial sites, may not be accessible for the 
adsorption due to the CPT molecule dimension and the site diameter. Aggregated pores or 
inter-bundle pores are also the possible sites for the adsorption of CPT.  
 
 
 
Grooves  
 
Interstitial sites  
 
External surface of 
outer SWCNTs 
 
Hollow sites  
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4.3.5. Characterization of CPT-adsorbed Ox-SWCNTs 
 
 
 
Fig. 4.10. TEM images of (a) Ox-SWCNTs and (b) CPT-adsorbed Ox-SWCNTs. 
 
FTIR, TGA and determination of pore structures by adsorption of N2 at 77 K of the 
samples before and after CPT adsorption were also carried out to confirm the presence of CPT 
molecules adsorbed on the Ox-SWCNTs. The TEM images of the Ox-SWCNTs and CPT-
adsorbed Ox-SWCNTs are shown in Fig. 4.10. These results show TEM image of CPT-
adsorbed Ox-SWCNTs is close to that of the Ox-SWCNTs, making it difficult to observe 
directly the adsorbed CPT on the Ox-SWCNTs.  
 
 
Fig. 4.11. FTIR spectra of the Ox-SWCNTs and CPT-adsorbed Ox-SWCNTs.   
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The FTIR spectra of CPT adsorbed on the Ox-SWCNTs as shown in Fig. 4.11 indicate 
the presence of some new apparent bands derived from CPT compared to the Ox-SWCNTs 
alone. The band at the interval of ~1020 to 1340 cm
-1 
is assigned to C–N stretching. The sharp 
peak at ~1600 cm
-1 
is associated to C=N, and at ~1740 to 1750 cm
-1
 is associated to C=O 
from ester functional group on CPT. The obtained TGA data for CPT, the Ox-SWCNTs and 
CPT-adsorbed Ox-SWCNTs complex are shown in Fig. 4.12. TGA analyses were carried out 
under flowing nitrogen at a heating rate of 5 K/min from 303 K up to 723 K. CPT and CPT 
adsorbed on the Ox-SWCNTs started to decompose at different temperatures. The main 
burning of CPT was found at ~530 K, whereas for CPT adsorbed on the Ox-SWCNTs shifted 
to a lower temperature, ~510 K. This shift occurred probably due to the fact that CPT 
adsorbed as a monolayer on Ox-SWCNTs and there are no interactions between the adsorbed 
CPT. By thinking about non-covalent intermolecular interactions, interaction between CPT 
molecules is stronger than intermolecular interaction between CPT and Ox-SWCNTs. They 
can stack together efficiently and indicate a higher main burning temperature than that of 
CPT-adsorbed Ox-SWCNTs.  
 
 
Fig. 4.12. TGA profiles of of CPT, the Ox-SWCNTs and CPT-adsorbed Ox-SWCNTs.   
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Table 4.7 – Specific surface area and pore volume of Ox-SWCNTs and CPT adsorbed Ox-
SWCNTs. 
Parameter Ox-SWCNTs CPT – Ox-SWCNTs 
Specific surface area (BET)/m
2 
g
-1
 (0.01 – 0.05) 170  92 
Specific surface area (BET)/m
2
 g
-1
 (0.05 – 0.35) 224  97 
Total pore volume/cm
3
 g
-1
 0.51  0.39  
Micropore volume (DR)/cm
3
 g
-1
 0.07  0.04  
Mesopore volume/cm
3
 g
-1
 0.44  0.35  
 
 
 
Fig. 4.13. N2 adsorption isotherms of Ox-SWCNTs and CPT adsorbed Ox-SWCNTs samples 
at 77 K. Solid and open symbols represent the adsorption (A) and desorption (D) respectively. 
 
The nanoporosity changes of the Ox-SWCNTs affected by CPT adsorption can be 
observed from the adsorption isotherm of N2 at 77 K, as shown in Fig. 4.13 The CPT 
adsorption decreased the nitrogen adsorption amount at the whole range of pressure, 
indicating the nanopores of Ox-SWCNTs were partially blocked. The adsorption of CPT on 
the Ox-SWCNTs depressed the specific surface area and also micropore volume of the Ox-
SWCNTs as can be seen in Table 4.7. 
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4.4. Conclusions 
The quenching phenomenon, which is indicative of the interactions between CPT and 
the Ox-SWCNTs, was observed during this study. Thermodynamic parameters at different 
temperatures demonstrated that the interaction between the Ox-SWCNTs and CPT in this 
particular condition was feasible, spontaneous and exothermic. Langmuir model was found to 
be closer to behavior implying a monolayer adsorption of CPT on the surface of the Ox-
SWCNTs. Freundlich exponent factor (n) of 1.47 lies in the range of 1 to 10 indicates that 
favorable condition for the adsorption of CPT. Weber-Morris kinetic model gave multiple 
linear regions, which suggested that adsorption may occur by multiple adsorption rates. 
Fourier transform infrared spectroscopy, thermogravimetry and determination of pore 
structures by adsorption of N2 at 77 K of the samples before and after CPT adsorption also 
exhibited the presence of CPT molecules adsorbed on the Ox-SWCNTs, indicating the 
potentialities of SWCNTs to be developed as a nanocarrier for water-insoluble anticancer 
agent CPT.  
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Chapter 5 
Non-covalent conjugation of methotrexate on oxidized single 
walled carbon nanotubes 
 
5.1. Introduction 
Cancer has a reputation as a deadly disease with high prevalence in the world. By 2030, 
it is estimated that there will be ~26 million new cancer cases and 17 million cancer deaths 
per year [1]. Cancer is usually treated with chemotherapy, radiation therapy and surgery, but 
most often, the main cancer treatment is chemotherapy utilizing highly potent drugs. Treating 
cancer is a challenge because cancer chemotherapeutic agents are cytotoxic and could rarely 
differentiate cancer cells from normal cells. This leads to the destruction or impairment of 
vital organs in addition to killing cancer cells even at therapeutic dose levels, if their bio-
distribution is not properly controlled and the therapeutic agents not targeted towards the 
cancer cells or tissues [2,3]. In addition to overcome this issue, nowadays, many of research 
are addressed to find a possible new cancer treatment. It may be a new drug, a new invention, 
or a new way to give treatment. Relating to the new way, carbon nanotubes (CNTs) are one of 
nanomaterials which being actively explored by researchers, scientists and academicians for 
the development of new, safe and effective nanocarrier as a drug delivery tool for anticancer 
agents [4]. Many features are possessed by CNTs that make them become an attractive 
material for drug delivery carrier of anticancer drugs. Their small size, high surface area, inert 
chemical composition, unique physical properties, and ability to enter cells via endocytosis 
process or passive physical penetration have made them as a good candidate for transport a 
variety of potential anticancer drugs. Furthermore, as nanocarriers CNTs also tend to 
accumulate in tumor tissue much more than they do in normal tissues and known as the 
enhanced permeability and retention (EPR) effect [5].  
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Fig. 5.1. The structure of MTX. 
 
Methotrexate (MTX) is folic acid antagonist which works by inhibiting dihydrofolate 
reductase, an enzyme that participates in the tetrahydrofolate synthesis. Methotrexate has been 
used extensively in chemotheraphy as the first-line therapy for the treatment of certain human 
cancers including leukemia, lymphoma, head and neck cancer, breast cancer, skin cancer, and 
lung cancer [6-8]. Currently, it is also being used in the treatment of refractory rheumatoid 
arthritis and chronic inflammatory disorders including psoriasis, primary biliary cirrhosis and 
intrinsic asthma [9]. However, to get an effective and efficient use of MTX in chemotheraphy, 
some limitations such as poor water solubility, high toxicity due to its lack of selectivity, low 
cellular uptake, and short half-life time of MTX in plasma still impending its clinical 
application. To overcome these limitations, various types of MTX conjugation with 
nanoparticles currently have been investigated and developed as a drug delivery system for 
MTX. Samori et al. had reported on the conjugation of MTX with multi-walled carbon 
nanotube (MWCNTs) through different cleavable linkers exploiting the ammonium 
functionalities introduced by 1,3-dipolar cycloaddition reaction of azomethine ylides to the 
nanotubes [10]. Jiang et al. prepared the covalent conjugation of MTX onto dedoped 
Fe3O4/polypyrrole by forming peptide bond through coupling chemistry involving 
carbodiimide dehydrant and studied its cytotoxic effect against HeLa cells [11]. Jain et al. 
used polysorbate 80 coated poly-lactic-co-glycol acid nanoparticles loaded with MTX-
transferin conjugates and proposed the use of this conjugates for a better understanding of 
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brain cancer [12].  Basically, all of these and most others research prepared the conjugates 
contain a link between carboxyl group of methotrexate and amine or hydroxyl group of carrier 
system or linkers. In the current study we studied comprehensively the interaction of MTX 
with the Ox-SWCNTs through the physical adsorption of MTX on the Ox-SWCNTs. This 
non-covalent conjugation was performed in order to explore a new approach to functionalize 
Ox-SWCNTs with MTX and gain comprehensive results which can be a foundation for the 
development of the Ox-SWCNTs as a new, safe and effective nanocarrier for MTX.  
 
5.2. Experimental 
5.2.1. Material 
The Ox-SWCNTs were synthesized by two step processes of purification and oxidation 
method using the mixture of concentrated sulfuric acid (H2SO4) and nitric acid (HNO3) as 
presented in chapter 3 (method A). Methotrexate and all other chemicals were purchased from 
Wako Pure Chemical Industries, Ltd. (Tokyo, Japan). 
 
5.2.2. Adsorption experiments 
5.2.2.1. Factors affecting the adsorption of MTX by Ox-SWCNTs 
The objective of this study is to investigate the factors that influence the interactions 
between MTX and Ox-SWCNTs. The effects of pH, temperature and polarity of solvent were 
studied. In order to evaluate the effects of pH, adsorptions were studied under different 
conditions of pH (pH of 1, 3, 5, 7, and 10) stirring for 48 h at 298 K. Concentrations of the 
Ox-SWCNTs were fixed at 12.5 mg L
–1
 whereas concentrations of MTX were varied in the 
range of 0 to 16.5 mg L
–1
. Influence of the solvent polarity on the adsorption of MTX was 
observed by varying the composition of water/dimethyl sulfoxide (DMSO) mixed solvents, 
from 25% to 75% of DMSO (in terms of volume ratios (v/v)). The adsorption samples then 
were stirred for 48 h at 298 K with concentrations of Ox-SWCNTs were fixed at 12.5 mg L
–1
 
and concentrations of MTX were varied in the range of 0 to 29.5 mg L
–1
. The effect of 
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temperature on the adsorption was the next variable studied which was carried out at three 
different temperatures; 298, 308 and 318 K.  
 
5.2.2.2. The equilibrium sorption and isotherms studies 
The equilibrium sorption of MTX on Ox-SWCNTs was observed by mixing MTX and 
Ox-SWCNTs in two different solvent systems, 0.1 M HCl and 25% of DMSO.  These 
mixtures then were shaken for 48 h at 298 K. Initial concentrations of MTX were varied from 
1.45 to 29.0 mg L
–1
 for 0.1 M HCl system and in the range of 7.63 to 76.3 mg L
–1
 for 25% of 
DMSO system, whereas the concentration of Ox-SWCNTs was fixed. The mixtures were 
filtered through a Millipore system (0.2 μm OmniporeTM filter) then the absorbance from the 
filtered solutions was analyzed by JASCO V-670 Spectrophotometer. The amounts of MTX 
adsorbed by the Ox-SWCNTs were calculated by the mass balance equation: 
 
   
        
 
 (1)                                                                            
 
where Qe is the amount of MTX adsorbed per gram of Ox-SWCNTs at equilibrium (mg g
–1
), 
C0 is the initial concentration of MTX (mg L
–1
), Ce is the equilibrium concentration of MTX 
(mg L
–1
), m is the mass of Ox-SWCNTs (g) and V is the volume of solution (L). The 
adsorption isotherm models, Langmuir and Freundlich models were used to fit the equilibrium 
isotherm data.  
 
5.2.2.3. Kinetics study 
Kinetics experiments were carried out at 298 K in two systems of solvent. A known 
amount of Ox-SWCNTs and MTX were mixed in 0.1 M HCl with the initial concentration 
was 15.7 mg L
–1
 of MTX and 12.5 mg L
–1
 of Ox-SWCNTs. For kinetics experiments with 
25% of DMSO as a solvent, the initial concentration was 13.6 mg L
–1
 of MTX and 12.5 mg L
–
1
 of Ox-SWCNTs. At given time intervals, the equilibrium concentration of MTX was 
measured until it remained constant using JASCO V-670 Spectrophotometer. The amounts of 
MTX adsorbed by the Ox-SWCNTs were calculated by the mass balance equation. The 
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pseudo first-order, pseudo second-order and Weber-Morris kinetics models then were 
employed to investigate the kinetics of adsorption MTX on Ox-SWCNTs.  
 
5.2.2.4. Thermodynamics studies 
Thermodynamic parameters were calculated from the equilibrium constant Kd data 
which were obtained from the effect of temperature on the adsorption study. Kd can be 
calculated by the following equation [13]: 
 
   
       
  
 
 
 (2)                                                                            
 
where C0 (mg L
–1
) and Ce (mg L
–1
) are the initial concentration and equilibrium concentration 
of MTX, m is the mass of Ox-SWCNTs (g) and V is the volume of solution (L). By plotting 
ln Kd vs. T
-1, enthalpy (ΔHº) and entropy (ΔSº) can be extracted from the slope and intercept 
with R is the ideal gas constant (8.314 J K
-1
 mol
-1
).  
 
     
   
 
 
   
  
             (3)         
 
Gibbs free energy (ΔGº) then can be calculated using the following equation: 
 
                                               (4)       
 
5.3. Results and discussion 
5.3.1. Non-covalent conjugation of MTX on Ox-SWCNTs 
5.3.1.1. Influencing factors 
In order to gain a deeper understanding about MTX sorption on the Ox-SWCNTs, the 
first issue to be investigated is the evaluation of the possible impact of environmental 
conditions during the MTX loading step in the adsorption process. The effects of pH, 
temperature and solvent polarity were studied.  
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Fig. 5.2. Loading of MTX to Ox-SWCNTs through non-covalent attachment at pH ranging 
from 1 to 10. 
 
Based on its structure, MTX is ionizable organic chemical and may become ionized at 
environmental pH which altering their adsorption characteristics. MTX is also able to attach 
to the surface of bulk π system by π‒π interactions due to their inherent π electron-rich 
structure. These two characteristics will make its binding to nanotubes become pH-dependent. 
Fig. 5.2 shows that, as expected, binding of MTX to the Ox-SWCNTs clearly was influenced 
by the environmental pH. MTX sorption capacity was greater with decreasing pH, with 
maximal binding at pH 1. At low pH, attractive interaction between MTX and the Ox-
SWCNTs is stronger than at high pH due to increase of hydrophobic interaction. Adsorption 
at low pH probably is also influenced by π‒π electron donor-acceptor (EDA) interactions. 
MTX contains pH-sensitive amine groups that are positively charged at low pH to form the 
cationic (hetero)aromatic amines which are capable to act as π acceptors in forming π+‒π 
electron donor-acceptor (EDA) interactions with the π electron-rich, the hexagonal sp2-carbon 
sheet of the Ox-SWCNTs. This attractive force along with hydrophobic interaction increased 
the adsorption of MTX at low pH as shown in Fig. 5.2. At high pH, carboxylic groups at both 
of MTX molecule and Ox-SWCNTs will be ionized, and thus make the net surface charge of 
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both to be negatively charged and make the repulsive forces between them being stronger, 
indicated by low adsorption of MTX. Increased pH also leads to increased hydrophilicity and 
solubility of MTX, and thus decreased the adsorption of MTX on the Ox-SWCNTs.  
 
 
 Fig. 5.3. The adsorption of MTX on Ox-SWCNTs in organic solvent (DMSO) with different 
polarity. 
 
Solvent polarity is the next variable which was studied in order to see its effect on MTX 
sorption. Fig. 5.3 shows the effect of solvent polarity (represented by variation of DMSO 
percentage in the solvent) on MTX sorption to the Ox-SWCNTs. As shown in this figure, 
sorption capacities of MTX were high under lower polarity and decreased with the increase of 
polarity. From this result, by conducting adsorption experiment in organic solvent in different 
polarity, we can see the relative high contribution of hydrophobic interaction to the overall 
adsorption of MTX on Ox-SWCNTs. The effect of temperature on the adsorption of MTX 
would be later discussed in thermodynamics studies.    
 
5.3.1.2. The equilibrium sorption and isotherms studies 
The adsorption of MTX on Ox-SWCNTs was found to be relatively fast process as we 
can see in Fig. 5.4. which show the time course of MTX adsorption on Ox-SWCNTs. For 
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both of solvent systems, just in first few hours the adsorption of MTX was found to be rapid 
due to a higher availability of active sites on the surface of Ox-SWCNTs and then became 
slower along with the increasing of contact time, before reaching equilibrium that was found 
to be achieved within 24 hours (6 hours for 25% DMSO and 24 hours for 0.1 M HCl). These 
relatively moderate rates and short times to reach equilibrium give an efficient in time and 
also can prevent the loss of MTX bioactivity that might be occurred during studies.  
 
 
Fig. 5.4. Time course of MTX adsorption on Ox-SWCNTs in two different solvent systems: 
(a) 0.1 M HCl with concentration of MTX was 15.7 (mg L
-1
) and Ox-SWCNTs was 12.5 (mg 
L
-1
), (b) 25% DMSO with concentration of MTX was 13.6 (mg L
-1
) and Ox-SWCNTs was 
12.5 (mg L
-1
). 
 
The initial concentration of MTX allowed a greater driving force to overcome the mass 
transfer resistances between the aqueous and solid phases of MTX leading to increase of 
equilibrium adsorption capacity. As shown in Table 5.1 and 5.2, the adsorption capacity of 
Ox-SWCNTs increased with increasing the initial concentration of MTX. However, also 
based on the results, at some points the increase in equilibrium adsorption capacity seems to 
stall due to saturation as indicated by the initial concentration of MTX which was higher than 
14.5 mg L
-1
 in 0.1 M HCl system. Over this concentration the equilibrium adsorption capacity 
were constant at approximately 230 mg g
-1
. 
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Table 5.1 – Effect of the initial MTX concentration on MTX sorption onto the Ox-SWCNTs 
in 0.1 M HCl. 
Conc. of MTX (mg L
-1
) 
Conc. of  Ox-
SWCNTs (mg L
-1
) 
MTX loading capacity of Ox-SWCNTs 
(mg gr
-1
) 
1.45 12.5 103 ± 6.14 
4.35 12.5 165 ± 3.66 
5.80 12.5 182 ± 3.02 
7.25 12.5 205 ± 24.0 
8.70 12.5 183 ± 11.9 
14.5 12.5 233 ± 25.5 
29.0 12.5 232 ± 21.7 
 
Table 5.2 – Effect of the initial MTX concentration on MTX sorption onto the Ox-SWCNTs 
in 25% DMSO. 
Conc. of MTX (mg L
-1
) 
Conc. of  Ox-
SWCNTs (mg L
-1
) 
MTX loading capacity of Ox-SWCNTs 
(mg gr
-1
) 
7.63 12.5 133 ± 26.0 
11.4 12.5 168 ± 1.99 
15.3 12.5 216 ± 36.2 
30.5 12.5 341 ± 66.8 
45.8 12.5 392 ± 11.6 
61.0 12.5 518 ± 19.4 
76.3 12.5 557 ± 40.5 
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Table 5.3 – Langmuir and Freundlich isotherm constants for the adsorption of MTX on Ox-
SWCNTs. 
 
0.1 M HCl as a solvent 
Langmuir  Freundlich 
Qo / mg g
-1
 KL / L mg
-1
 RL R
2
  n Kf  / (mg g
-1
)(L mg
−1
)
1/n
 R
2
 
256 0.64 0.06-0.52 0.93  4.72 130 0.78 
 
25% DMSO as a solvent 
Langmuir  Freundlich 
Qo / mg g
-1
 KL / L mg
-1
 RL R
2
  n Kf  / (mg g
-1
)(L mg
−1
)
1/n
 R
2
 
667 0.04 0.27-0.81 0.98  1.69 46.7 0.99 
 
Isotherms were obtained, for each solvent system, by measuring the MTX concentration 
at equilibrium. The classic equations of Langmuir and Freundlich models as stated in equation 
5 and 6 were used to analyze the equilibrium isotherm data in order to describe the 
distribution of MTX between adsorbent and solution in the equilibrium state. Langmuir 
adsorption parameters were determined by the linear form of Langmuir equation as: 
 
 
  
 
 
  
 
 
      
 (5)                                                                            
 
where Ce is the equilibrium concentration of MTX (mg L
-1
), Qe is the amount of MTX 
adsorbed per gram of Ox-SWCNTs at equilibrium (mg g
-1
), Qo is the maximum monolayer 
coverage capacity (mg g
-1
), and KL is the Langmuir isotherm constant (L mg
-1
). Freundlich 
adsorption parameters were also determined by its linear form equation: 
 
            
 
 
      (6)                                                                            
 
where Ce is the equilibrium concentration of MTX (mg L
-1
), Qe is the amount of MTX 
adsorbed per gram of Ox-SWCNTs at equilibrium (mg g
-1
), Kf is the Freundlich isotherm 
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constant ((mg g
-1
)(L mg
−1
)
1/n
) and n is the Freundlich exponent factor. The comparing plots of 
the theoretical Langmuir and Freundlich isotherms with the experimental data of adsorption 
MTX on Ox-SWCNTs in each solvent system are shown in Fig. 5.5 and Fig. 5.6 respectively. 
The calculated Langmuir and Freundlich parameters and related coefficients are listed in 
Table 5.3.  
 
 
Fig. 5.5.  (a) Linear plot of Langmuir isotherm model, (b) linear plot of Freundlich isotherm 
model, (c) fitting curve of Langmuir-type model, and (d) fitting curve of Freundlich-type 
model of MTX sorption on Ox-SWCNTs in 0.1 M HCl. 
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Fig. 5.6.  (a) Linear plot of Langmuir isotherm model, (b) linear plot of Freundlich isotherm 
model, (c) fitting curve of Langmuir-type model, and (d) fitting curve of Freundlich-type 
model of MTX sorption on Ox-SWCNTs in 25% of DMSO. 
 
As we can see from the results, the Langmuir-type model yielded better fit with higher 
R
2 
value compared to the Freundlich-type model when we conducted the adsorption 
experiment in 0.1 M HCl. It implies that the adsorption might occurs at the specific 
homogeneous sites within the adsorbent (Ox-SWCNTs) to form a monolayer adsorption and 
all of these sites are equivalent. Theoretical amount of MTX at complete monolayer coverage 
(Qo) based on the Langmuir-type model was 256 (mg g
-1
) which can be defined as the 
maximum adsorption capacity of the Ox-SWCNTs as the adsorbent. The essential parameter 
of Langmuir model is equilibrium parameter, RL, which indicates whether the adsorption is 
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unfavorable (RL > 1), linear (RL = 1), favorable (0 < RL < 1) or irreversible (RL = 0) can be 
defined by the following equation: 
 
   
 
        
 (7)                                                                            
 
where KL is the Langmuir isotherm constant (L mg
-1
) and C0 is the initial concentration of 
MTX (mg L
-1
). In this study, RL values for MTX adsorption over Ox-SWCNTs were less than 
one but greater than zero, indicating a favorable adsorption. A different result was obtained 
from the sorption study of MTX which was performed in 25% DMSO. The plot of log Qe 
versus log Ce of Freundlich model fitted nicely for the adsorption data indicating the adsorbed 
MTX was multilayer due to the hydrophobic interactions.  The obtained Freundlich exponent 
factor (n) of 1.69 which lies in the range of 1 to 10 (favorable condition for the adsorption) 
reflects how favorable the adsorption of MTX on Ox-SWCNTs is. The value of n confirms 
the favorable condition for the adsorption. 
 
5.3.1.3. Kinetics study 
Adsorption kinetic is expected to provide information about the underlying mechanisms 
of the adsorption and also the optimum conditions for a pilot-scale process. As shown in Fig. 
5.4, the adsorption capacities increased quickly in the first few hours and then increased 
slower thereafter. These experimental kinetic data were analyzed by two kinetics models, 
pseudo first-order model and pseudo second-order model. The pseudo first-order kinetic 
model is expressed by the following equation: 
 
                        (8a) 
                                                                       
                                                                                                                        (8b) 
 
where qt is the amount of MTX adsorbed at time t (mg g
-1
), qe is the amount of MTX 
adsorbed at equilibrium (mg g
-1
) and k1 is the pseudo first-order rate constant (min
-1
). While 
the pseudo second-order kinetic model is expressed as:  
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   (9a)  
 
 
  
 
 
    
  
 
  
 (9b)                                                                            
 
where qt is the amount of MTX adsorbed at time t (mg g
-1
), qe is the amount of MTX 
adsorbed at equilibrium (mg g
-1
) and k2 is the pseudo second-order rate constant (g mg
-1
 min
-
1
). The plots for both of the models are shown in Fig. 5.7.  
 
 
Fig. 5.7. Linear regressions of kinetics plot of the adsorption of MTX on Ox-SWCNTs. 
Fitting by pseudo first-order model for (a) 0.1 M HCl as a solvent and (b) 25% DMSO as a 
solvent. Fitting by pseudo second-order model for (c) 0.1 M HCl as a solvent and (d) 25% 
DMSO as a solvent. 
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The kinetic parameters calculated from these models and the correlation coefficients R
 
are listed in Table 5.4 for 0.1 M HCl solvent system and 25% DMSO solvent system 
respectively. For both of solvent systems, the kinetics model and the overall adsorption 
capacity were well described by the pseudo second-order kinetic model better than the pseudo 
first-order kinetic model. The correlation coefficients for both of solvent systems of the 
pseudo-second order kinetic model show relatively high values (>0.999). The calculated 
amount of MTX adsorbed at equilibrium (qe,cal) that was obtained from the pseudo-second 
order kinetic model and the experimental values (qe,exp) are close as shown in Table 5.4, 
indicating that the pseudo second-order kinetic model is representing well the experimental 
kinetic data of MTX on Ox-SWCNTs.  
 
Table 5.4 – Kinetic parameters for the adsorption of MTX on Ox-SWCNTs (concentration of 
Ox-SWCNTs: 12.5 mg L
-1
; temperature 298 K). 
Solvent C0
a
 qe,exp
b
 
Pseudo first-order  Pseudo second-order 
k1
c
 qe,cal
b
 R  k2
d
 qe,cal
b
 R 
0.1 M HCl 15.7 230 2.4 x 10
-3
 63.9 0.95  3.3 x 10
-4 
 222 1 
25% DMSO 13.6 192 1.16 x 10
-2 
 48.7 0.99  1.22 x 10
-3 
 189 1 
  
  
      
 Weber-Morris 
 Solvent C0
a
 kd1
e
 C1 R1 kd2
e
 C2 R2 kd3
e
 C3 R3 
 0.1 M HCl 15.7 45.6  8.69  0.98 2.23 164 0.98 0.36 209 0.98 
 25% DMSO 13.6 41.6  12.3  0.96  2.82 147 0.98 0.20 184 0.90 
*a
 (mg L
-1
)   
b
 (mg g
-1
)   
c
 (min
-1
)   
d
 (g mg
-1
 min
-1
)   
e
 (mg g
-1
 min
-1/2
) 
 
On the other hand, the correlation coefficients obtained from the pseudo-first order 
kinetic model were lower than 0.999 and there was also a significant difference between the 
experimental and calculated qe values of this model. This result shows that the pseudo-first 
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order kinetic model is not ideal for describing the kinetics of adsorbing MTX onto Ox-
SWCNTs.  
 
 
Fig. 5.8. Weber-Morris kinetic plots for the adsorption of MTX on Ox-SWCNTs in (a) 0.1 M 
HCl and (b) 25% DMSO.  
 
The diffusion mechanism during adsorption process of MTX onto Ox-SWCNTs was 
investigated by fitting the kinetics data with following equation of Weber-Morris kinetic 
model: 
 
      
 
     (10)                                                                            
 
where qt is the amount of MTX adsorbed at time t, kd is the intra-particle diffusion rate 
constant (mg g
-1
 min
-1/2
) and C is the intercept which is related to the thickness of boundary 
layer. The similar plot of Weber-Morris kinetic model was obtained from both of experiment 
conditions, adsoption process in 0.1 M HCl and 25% DMSO. The calculated parameters from 
the Weber-Morris kinetic model show that the adsorption process of MTX on Ox-SWCNTs is 
quite complex. The value of C which is not equal to zero suggests that the intra-particle 
diffusion is not the rate-determining step and the adsorption process involve both intra-
particle diffusion and surface diffusion. As shown in Fig. 5.8a and Fig. 5.8b, the plot of qt to 
t
1/2 
exhibits multi linearity with different slopes. The first linear part is representing the fastest 
adsorption stage due to the boundary layer diffusion effect. The second linear part is attributed 
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to the diffusion in the liquid contained in the pores and along the pore walls which is referred 
to as the intra-particle diffusion. The last linear part is the final equilibrium stage, where the 
rate of the intra-particle diffusion starts to slow down.  
 
5.3.1.4. Thermodynamics study 
The adsorption experiments at different temperature were performed to evaluate the 
influence of temperature on the adsorption mechanism and it was demonstrated that the 
adsorption was affected by temperature. Thermodynamic parameters such as changes in 
Gibbs free energy (ΔGº), enthalpy (ΔHº), and entropy (ΔSº) were evaluated in order to get 
information of the energetic changes that is associated with the adsorption mechanism of 
MTX on Ox-SWCNTs.  
 
Table 5.5 – Thermodynamic parameters of MTX adsorption on Ox-SWCNTs. 
Solvent Temperature / K ln Kd ΔHº / kJ mol-1 ΔGº / kJ mol-1 ΔSº / J mol-1 K-1 
0.1 M HCl 
298 2.62 
-51.8 
-6.48 
-151 308 2.23 -5.72 
318 1.29 -3.42 
 298 2.23 
-15.8 
-5.52 
-34.4 25% DMSO 308 2.00 -5.12 
 318 1.83 -4.84 
 
A value of ΔHº was calculated from the slope of plot between ln Kd versus 1/T, as 
shown in Fig. 5.9. Referring to the thermodynamic parameters which are listed in Table 5.5, 
for both of adsorption conditions, the negative ΔHº indicates that the adsorption of MTX on 
Ox-SWCNTs is an exothermic process. The negative value of ΔGº at all of temperatures 
denotes that the adsorption of MTX by Ox-SWCNTs is spontaneous and thermodynamically 
favorable. Furthermore, a more negative value of ΔGº along with temperature decrease 
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implies a greater driving force of adsorption that leading to a higher adsorption capacity or in 
other words the performance of MTX adsorbed on the Ox-SWCNTs was more favorable at 
lower temperatures.  
 
 
Fig. 5.9. van’t Hoff plot for the adsorption of MTX on Ox-SWCNTs in (a) 0.1 M HCl and (b) 
25% DMSO. 
 
5.3.1.5. Characterization of MTX-adsorbed Ox-SWCNTs 
Additional evidences for the non-covalent conjugation are deduced by Raman and FT-
IR spectroscopy. Raman Spectra of Ox-SWCNTs and MTX/Ox-SWCNTs show two 
characteristic bands at around 1580 cm
-1 
(in-plane vibration G-band) and 1350 cm
-1 
(disordered vibration D-band) which are the characteristic bands of the first-order SWCNTs. 
D-band as the disordered mode can be used to diagnose the additional disruptions in the 
hexagonal framework of Ox-SWCNTs as a result of covalent conjugation. Comparing Raman 
spectra of Ox-SWCNTs, MTX/Ox-SWCNTs (pH 1), and MTX/Ox-SWCNTs (DMSO 25%) 
in Fig. 5.10, little variation of the intensity ratio between D to G band (ID/IG) was observed 
indicating that MTX was associated to the surface of Ox-SWCNTs through the non-covalent 
conjugation. The attachment of MTX was also supported by the FTIR spectra of MTX 
adsorbed on the Ox-SWCNTs as shown in Fig. 5.11 that indicates the presence of some new 
apparent bands derived from MTX compared to the Ox-SWCNTs alone. The bands at ~1208 
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cm
-1
 related to C–N stretching vibration, at ~1511 and ~1607 cm-1 are associated to N–H 
bending vibration. 
 
 
Fig. 5.10. Raman spectra of the Ox-SWCNTs and MTX-adsorbed Ox-SWCNTs. 
 
 
Fig. 5.11. FTIR spectra of the Ox-SWCNTs and MTX-adsorbed Ox-SWCNTs. 
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5.4. Conclusions 
In summary, the adsorption of MTX on Ox-SWCNTs under different conditions was 
systematically studied. The adsorption isotherms, adsorption kinetics and influencing 
parameters have been investigated and established. Ox-SWCNTs possessed a proper 
adsorption capacity for MTX, which was found strongly dependent on pH value and polarity 
of the solution. MTX sorption isotherm data were fitted well to Langmuir isotherm and the 
monolayer sorption capacity was found to be 256 mg g
-1 
when the sorption process was 
performed in 0.1 M HCl. For the sorption of MTX on Ox-SWCNTs in 25% DMSO, 
Freundlich model fitted nicely for the adsorption data indicating the adsorbed MTX was 
multilayer. The adsorption of MTX on Ox-SWCNTs was found to be relatively fast process 
and the pseudo second-order kinetic model agreed very well the dynamic data. Plot of Weber-
Morris kinetic model revealed the adsorption process involving both intraparticle diffusion 
and surface diffusion. It has been shown that Ox-SWCNTs are appropriate carriers of MTX 
and these results are expected would stimulate more interest in developing Ox-SWCNTs as a 
carrier for drug delivery system of MTX. 
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General Conclusions 
 
One of the essential factors in the development of nanoparticles as a drug delivery 
system (DDS) for cancer therapies is the availability of promising novel materials to be 
developed as a carrier in DDS. In this study, we have shown the Ox-SWCNTs are such 
materials that have potentialities to be developed as an efficient and more suitable nanocarrier 
for water-insoluble anticancer drugs. Camptothecin (CPT) and methotrexate (MTX) were 
selected as model drugs and their fundamental interaction with Ox-SWCNTs has been 
investigated.  
In chapter 3, study was focused on engineering an establish method of purification and 
oxidation of SWCNTs in order to produce feasible oxidized SWCNTs (Ox-SWCNTs) that are 
suitable for use as a starting material in biomedicine research involving SWCNTs. The 
developed method allowed the removal of catalyst impurities including metal impurities 
enclosed in carbon shells that was confirmed by TGA. Other characterizations also showed 
the obtained Ox-SWCNTs are well dispersed in aqueous solutions and contain abundant 
carboxylic acid groups that open possibilities for further conjugation of this material with 
different biological or bioactive molecules including drugs, proteins, and targeting ligands for 
a variety of biomedical research purposes. 
In chapter 4, systematic evaluation of the interaction between CPT and the Ox-SWCNTs 
was performed with the purpose to explore the potentialities of Ox-SWCNTs to be developed 
as a nanocarrier for CPT. Loading CPT on Ox-SWCNTs through the physical adsorption 
process was investigated and the results showed the presence of CPT molecules adsorbed on 
the Ox-SWCNTs. The quenching phenomenon, which is indicative of the interactions 
between CPT and the Ox-SWCNTs, was observed during this study and can be used as the 
basis of analysis for monitoring the adsorption of CPT. The adsorption of CPT on Ox-
SWCNTs was found to be dependent on concentration and adsorption temperature. 
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In chapter 5, non-covalent conjugation was performed in order to explore a new 
approach to functionalize Ox-SWCNTs with MTX and gain comprehensive results which can 
be a foundation for the development of the Ox-SWCNTs as a new, safe and effective 
nanocarrier for MTX. The results showed Ox-SWCNTs possess a proper adsorption capacity 
for MTX, which was found strongly dependent on pH value and polarity of the solution. 
 It has been shown that Ox-SWCNTs are appropriate carriers for water-insoluble 
anticancer drugs and these results are expected would motivate and stimulate more interest in 
research to develop Ox-SWCNTs as a carrier for drug delivery system of water-insoluble 
anticancer drugs. 
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